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GENERAL INTRODUCTION 
Organic synthesis, with the invention of new synthetic strategies and technologies, has 
evolved from largely empirical approaches for the preparation of relatively simple molecules 
to sophisticated strategies for the construction of molecules with considerable structural and 
functional complexity. Organic synthesis is employed to synthesize the natural product and 
its analogs for the discovery of new drugs. The development of new synthetic methodologies 
in the course of total synthesis is imperative for the efficient synthesis of drug candidates. 
Apart from the practical applications, the pursuit of efficient syntheses of complex natural 
products is both gratifying and truly enjoyable. 
Chapter One describes the development of annulation reaction for the construction of 
five-, six- and seven- membered rings. Chapter Two describes a direct approach to the 
synthesis of methyllycaconitine, a representative of the aconitine alkaloids. The numbering of 
the compounds, schemes and references are independent in each section. 
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CHAPTER 1 
ANNULATIONS VIA DIANIONS: FORMATION OF FIVE-, SIX-AND SEVEN-
MEMBERED RINGS 
Introduction 
C,C-Dianions, such as those shown in Figure 1, are generated by two sequential 
deprotonations. They have a long and diverse history and continue to serve as important 
synthetic reagents.1"6 C,C-Dianions are categorized based on the location of deprotonation. 
When sequential deprotonation occurs at the same carbon atom, 1,1-dianions are formed. 
When sequential deprotonation occurs at adjacent carbons, 1,2-dianions are formed. When 
sequential deprotonation occurs at carbon sites one atom apart, 1,3-dianions are formed as 
shown in Figure 1. The 1,3-(C,C) dianions have been most widely used in organic synthesis 
owing to their ready access and predictable reactivity. 
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Figure 1. Examples of C,C-dianions 
It is no surprise that investigators have made extensive use of these readily-accessed 
3 
dianions in synthesis. As an introduction to their utility, a pictorial survey of some natural and 
unnatural products prepared using dianions is shown in Figure 2. 
Figure 2. Synthetic products resulting from the use of 1,3-(C,C)-dianions. 
Dianion-based [3+3] Annulation 
Cyclohexenes are generally prepared by Diels-Alder reactions or Robinson annulation 
reactions.7 There are only a few examples where cyclohexenes are prepared by bringing 
together two three-carbon units. In all of these cases, a 1,3-(C,C) dianion acts as one of the 
two units. Mordini reported a novel a Hylic stannane reagent which functions as a dianion 
equivalent.8 Recently, 3-trimethylstannyl-2[(trimethylstannyl)methyl]propene was used as an 
isobutene dianion equivalent. When treated with diacyl chlorides, a cyclic product was 
formed through a formal [3 + n] annulation process as shown in Scheme 1. 
isoretronecanol juvenile hormone O chalcogram 
gascardic acid 
4 
MegSn SnMeg 
A THF , reflux 
HO ^ OH 
93% yield 
O 
MesSn SnMeg A + CI CI THF , reflux 
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O 
O 
65% yield 
Scheme 1. 
Molander communicated an innovative approach to the synthesis of six-membered 
rings by use of a,p-epoxy aldehydes and iodomethyl-substituted allylic silanes (Scheme 2).9 
Allyltin trihalide (generated in situ) addition to the carbonyl of the epoxy aldehyde occurred 
with good diasteroselectivity. The combination of intramolecular Lewis acid catalysis and 
fluoride-induced epoxide ring opening leads to formation of six-membered rings with good 
diastereoselectivity at three contiguous stereocenters of the newly-formed ring. 
TMS 
V H20 
Scheme 2. 
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Moohoff reported an annulation using phosphorus-stabilized 1,3-(C,C) dianions.10 
Moohoff reacted unsaturated aldehydes with the dianion of phosphonate keto esters. This led 
to the formation of cyclohexenones as shown in Scheme 3. 
MeOs 
MeCr 
0 0 
/^|j'^^C02R + 
CO2R 
Scheme 3. 
Cooke and Magnus11 converted l-phenyl-3-phenylsulfonyl-2-propanone to its crimson 
red 1,3-dianion using two equivalents of LDA or sequential treatment with NaH and BuLi. 
They reacted it with 1,3-dibromopropane to give the annulated product in modest yield as 
shown in Scheme 4. 
BrCH2CH2CH2Br 
Scheme 4. 
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Results and Discussion 
As part of a program to develop terpene-based antiviral agents,12 we needed an efficient 
synthetic route to bicyclic segments present in sesquiterpenes such as illudin S.13 The 
cytotoxicity and anticancer activity of illudin S has been most extensively investigated.14 The 
target of the compound is believed to be DNA. The low therapeutic index of illudin S has 
precluded its development as a chemotherapeutic agent. However, the semisynthetic illudin 
analogue, 6-(hydroxymethyl)acylfulvene (HMAF) shows outstanding activity and is now in 
various Phase I, II, and III clinical trials.15 
The well-documented acid lability of cyclopropyl carbinols plus the ready availability of 
1,1-diacetylcyclopropane16 led us to evaluate a [3+3] annulation route to this system. We 
envisioned a reaction of a 1,3-(C,C) dianion with 1,1-diacetylcyclopropane to generate the 
bicyclic segment of the illudins. 
R = H illudin M 
R = OH illudin S illudin A 
illudin B 
O 
OH 
HMAF 
Figure 3. Cytotoxic sesquiterpenes 
OH 9 [3+3] 
G = CN, C02Et 
er 
w 
pKa = 25-30 |h q g 
h/T 2 equiv of base 
Exo-1,3-dianion 
Scheme 5. 
We reasoned that phosphonium salts bearing an electron-withdrawing group at the y-
position could generate the dianion. The phosphonium salts were prepared from 
corresponding halides as shown in Scheme 6. Having synthesized the dianion precursor, we 
tested our dianion annulation using 1,1-diacetylcyclopropane and phosphonium salt 2a.17 The 
results are summarized in Table 1. 
PPh, 
Toluene, reflux 
Br +PPh3Br-
1 
G = CN, C02Et 2a: G = CN 2b: G = C02Et 
Scheme 6. 
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Table 1 : [3+3] Annulations of 3-cyanopropyl phosphonium salts 
Entry Base Temp (time) Yield % 
1 LDA -78 °C 23 
2 LDA, HMPA -78 °C 27 
3 LDA -20 °C (2h) 39 
4 NaHDMS -20 °C (2h) trace 
5 LiTMP -20 °C (2h) 65 
Using LDA as base at -78 °C gave a modest yield of 23%. Having achieved the 
desired cyclization, we tried optimizing the cyclization. Ultimately, the optimized cyclization 
was achieved using LiTMP as base at -20 °C. The successful annulation prompted us to 
evaluate the annulation with a variety of 1,3-diketones as electrophiles. The results are 
summarized in Table 2. 
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Table 2: [3+3] Annulation 
Entry G R R1 R2 Yield % 
(isomer ratio) 
1 CN CH2-CH2 Me Me 65(3:1) 3 
2 COOEt CH2-CH2 Me Me 54(5:1) 4 
3 CN Me, Me Me Me 61 5 
4 CN CH2"(CH2)2"CH2 Me Me 59 6 
5 CN Me, Me H Ph 53(1:1) 7 
6 COOEt Me, Me H Ph 48(1:1) 8 
The reaction of dianions with keto aldehydes18 (entries 5 & 6) gave only one 
regioisomer. We believe that anion next to the electron withdrawing group is more reactive 
than the phosphorane and hence it reacts preferentially with the more reactive aldehyde, as 
shown in Scheme 7. 
10 
PPh3 /=/ 
Scheme 7. 
Having achieved [3+3] annulations, we investigated the synthesis of five-membered 
rings. The results of the dianion additions to 1,2-dicarbonyl compounds are depicted in Table 
3. As anticipated, the yields of cyclopentenes were higher. 
Table 3: [3+2] Annulation 
Entry G Base R Yield % 
(isomer ratio) 
1 CN LiTMP Me 61(1:1) 9 
2 CN LiTMP 2-furyl 68(1:1) 10 
3 CN LiTMP Ph 80(1:1) 11 
4 COOEt LiTMP Ph 65(1:1) 12 
We also evaluated the synthesis of seven-membered rings. The results are depicted in 
Scheme 8. The initial adduct was oxidized using Jones reagent to give compounds 13 and 14. 
OH 
11 
CHO 
CHO 
Scheme 8. 
Q/g 
L 
HO HO G Jones 
Oxidation 
G= CN, 52% 13 
G= COOEt 44% 14 
Having achieved useful [ 3+4] annulation with modest success, we decided to change 
our dianion. We synthesized phosphonium salt 1519 and evaluated [4+2] annulation as shown 
in Scheme 9. Yields were fairly modest, probably due to the instability of the dianion. 
CN 
NBS 
CCI4 
2eq, LiTMP 
+PPh3Br-
2eq, LiTMP 
• 
+PPh3Br- Ph 
Ph3P 
Toluene, 
Br reflux 
Ph 
42% 
17 
© I  ©  
PPh3Br 
15 
Scheme 9. 
We also reacted 2b with cw-cyclopentane-l,3-dialdehyde.20 This reaction provided the 
12 
bicyclic adduct shown below in 38% yield. 
CHO 
.CHO 
2b 
LiTMP 
18 
The results above demonstrate that cyclizations using dianions derived from 2a and 2b 
can generate five-, six- and seven-membered ring compounds. The highly functionalized 
ring systems produced by the dianion annulations will be useful for the synthesis of natural 
products. Application of this methodology in the synthesis of core-structure of Sorcodictyin-
A22 is currently under progress. 
o 
OH 
C02Me 
Sarcodictyin A 
COOMe 
COOMe 
Scheme 10. 
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Experimental Section 
Unless otherwise noted, materials were obtained from commercial suppliers and used 
without purification. Tetrahydrofuran was distilled over sodium benzophenone ketyl. 
Dichloromethane and benzene were distilled over calcium hydride. All experiments were 
performed under an argon atmosphere unless otherwise noted. Nuclear magnetic resonance 
measurements were performed with either a Varian 300 MHz or Bruker 400 MHz instrument. 
All chemical shifts are reported relative to CDCI3 (7.26 ppm for 'H and 77.06 ppm for 13C), 
unless otherwise noted. Coupling constants (J) are reported in Hz with abbreviations: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet. High resolution mass spectra were 
recorded on a Kratos model MS-50 spectrometer and low resolution mass spectra were 
performed with a Finnegan 4023 mass spectrometer. Standard grade silica gel (60 A0, 32-63 
pm) was used for a flash column chromatography. 
Compound 3: 
To a solution of 2a (457 mg, 1.0 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of n-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The temperature of above solution was 
allowed to rise to -20 °C and stirred at -20 °C for a period of 90 min. The above solution was 
then cooled to -78 °C and 2,2-diacetylpropane (105 mg, 0.82 mmol) in 3 mL THF was added. 
The solution was warmed to 0 °C and was stirred at that temperature for an additional 1 h. 
The reaction was quenched with saturated ammonium chloride solution. The organic layer 
was extracted with ether (3 X 10 mL) and dried over MgSCU. The crude product was 
chromatographed on silica gel (H:EA = 5:1 to 3:1) to afford compound 3 as mixture of 
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isomers. 3a: 300 MHz ]H NMR (CDC13) 5 5.32 (1H, bs), 2.92 (1H, dd, J =  7.8 Hz, J =  4.5 
Hz), 2.50-2.60 (1H, m), 2.30-2.40 (1H, m), 1.42 (3H, m), 1.32 (3H, s), 1.00-1.10 (1H, m), 
0.80-0.95 (2H, m), 0.6-0.7 (1H, m); 75 MHz 13C NMR (CDC13) 5 136.0, 120.9, 117.7, 70.3, 
34.5, 28.6, 27.5, 24.2, 18.9, 8.3, 6.7. 3b: 300 MHz 'H NMR (CDC13) 6 5.40 (1H, bs), 2.86 
(1H, t,J= 6 Hz), 2.50-2.52 (2H, m), 1.45 (3H, m), 1.23 (3H, s), 1.13-1.20 (1H, m), 0.78-0.90 
(2H, m), 0.68-0.72 (1H, m); 75 MHz 13C NMR (CDCI3) 8 136.5, 121.2, 117.5, 70.1, 38.6, 
29.5, 28.2, 22.1, 18.9, 7.9, 7.4. HRMS m/z for CnH15NO calcd 177.1151, found 117.1154. 
Compound 4 
To a solution of 2b (456 mg, 1.0 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of zz-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and 2,2-
diacetylcyclopropane (105 mg, 0.82 mmol) in 3 mL THF was added. The solution was 
warmed to 0 °C and was stirred at that temperature for additional 1 h. The reaction was 
quenched with saturated ammonium chloride solution .The organic layer was extracted with 
ether (3X10 mL) and dried over MgSC>4. The crude product was chromatographed on silica 
gel (H:EA - 5:1) to afford compound 4 as mixture of isomers. 4a: 300 MHz *H NMR 
(CDCI3) ô 5.34 (1H, m), 4.17 (1H, q,J = 7.2 Hz), 2.77 (1H, d,J= 11.7 Hz), 2.33-2.41 (2H, 
m), 1.42 (3H, m), 1.27 (3H, t,J= 7.2 Hz), 1.25 (3H, s), 1.01-1.1 (1H, m), 0.80-0.90 (2H, m), 
0.49-0.52 (1H, m); 75 MHz 13C NMR (CDC13) 5 174.8, 136.2, 119.0, 70.1, 60.9, 49.3, 31.4, 
27.7, 21.5, 19.0, 14.8, 8.3, 6.1. 4b: 5.42 (1H, bs), 4.18 (2H, q, J= 7.2 Hz), 2.58-2.69 (2H, m), 
2.24-2.34 (1H, m), 1.42 (3H, m), 1.30 (3H, t, J =1.2 Hz), 0.82-0.94 (1H, m), 0.60-0.75 (3H, 
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m); 75 MHz l3C NMR (CDC13) 6 175.0, 135.8, 119.3, 70.3, 61.4, 49.0, 31.5, 26.4, 25.0, 19.0, 
14.8, 8.3, 6.3. HRMS m/z for C13H20O3 calcd 224.1412, found 224.1415. 
Compound 5 
To a solution of 2a (457 mg, 1 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of n-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and 2,2-
diacetylcyclopentane (126 mg, 0.82 mmol) in 3 mL THF was added. The solution was 
warmed to 0 °C and was stirred at that temperature for additional 1 h. The reaction was 
quenched with saturated ammonium chloride solution. The organic layer was extracted with 
ether (3X10 mL) and dried over MgSO#. The crude product was chromatographed on silica 
gel (H:EA = 5:1) to afford mixture of alcohols. 300 MHz 'H NMR (CDCI3) 5 5.04 (1H, bs), 
2.99 (1H, dd, J= 11.6 Hz, J= 6 Hz), 2.23-2.78 (2H, m), 1.92-2.01 (2H, m), 1.51-1.81 (6H, 
m), 1.38-1.50 (3H, m), 1.27 (3H, s); 75 MHz 13C NMR (CDC13) S 142.5, 121.4, 115.8, 74.3, 
53.9, 37.1, 36.4, 31.0, 28.8, 28.4, 27.8, 20.3, 19.8. HRMS m/z for C13H19NO calcd 205.1467, 
found 205.1469. 
Compound 6 
To a solution of 2a (457 mg, 1.0 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP, generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of w-BuLi 
(2.5 M solution in hexane) in 10 mL THF. The solution was allowed to rise to -20 °C and 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and 3,3-
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dimethyl-2,4-pentanedione (105 mg, 0.82 mmol) in 3 mL of THF was added. The solution 
was warmed to 0 °C and was stirred at that temperature for additional 1 h. The reaction was 
quenched with saturated ammonium chloride solution. The organic layer was extracted with 
ether (3X10 mL) and dried over MgSCX. The crude product was chromatographed on silica 
gel (H:EA - 5:1) to afford 6. 300 MHz 'H NMR (CDC13) S 5.16 (1H, bs), 3.13 (1H, dd, J 
=11.6 Hz, J = 6 Hz), 2.18-2.50 (2H, m), 1.64-1.64 (3H, m), 1.32 (3H, s), 1.08 (3H, s), 1.04 
(3H, s); 75 MHz 13C NMR (CDCI3) ô 141.72, 121.7, 116.7, 73.6, 42.5, 35.6, 28.4, 23.7, 20.6, 
20.4, 19.5. HRMS m/z for CnHnNO calcd 179.1310, found 179.1312. 
Compound 7: 
To a solution of 2a (457 mg, 1 mmol) in 5 mL of THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of «-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and 2,2-
dimethyl-3-oxo-3-phenylpropanaldehde (144 mg, 0.82 mmol) in 3 mL THF was added. The 
solution was warmed to 0 °C and was stirred at that temperature for additional 1 h. The 
reaction was quenched with saturated ammonium chloride solution .The organic layer was 
extracted w ith e ther (3 X 10 mL) and d tied o ver M gSC>4. The c rude p roduct w as flushed 
through a pad of silica to get crude mixture of 7. The mixture was dissolved in 4 mL of 
acetone and 0.5 mL of 2.7 M Jones reagent was added at 0 °C. After stirring at that 
temperature for 30 min quenched with 1 mL of isopropanol. Solvent was evaporated, 
dissolved in 5 mL of water and extracted with ethyl acetate (3X10 mL). Organic layer was 
dried with MgSO^ and the crude product was chromatographed on silica gel (H:EA = 5:1) to 
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yield compound 7a. 300 MHz *H NMR (CDC13) 8 7.28-7.40 (3H, m), 7.11-7.15 (2H, m), 
5.61 (1H, dd,J- 5.7 Hz, J= 2.4 Hz), 4.06 (1H, dd, J= 11.7, J= 6.7 Hz), 2.71-3.03 (2H, m), 
1.42 (3H, s), 1.25 (3H, s); 75 MHz 13C NMR (CDC13) 8 203, 147.9, 139.5, 129.3, 128.2, 
128.1, 127.7, 122.0, 116.6, 48.8, 38.2, 30.2, 27.2, 22.8. HRMS m/z for C15H15NO calcd 
225.1157, found 225.1157. 
Compound 8: 
To a solution of 2b (457 mg, 1 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of «-BuLi 
(2.5 M solution in hexane) in 10 mLof THF. The solution was allowed to rise to -20 °C and 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and 2,2-
dimethyl-3-oxo-3-phenylpropanaldehde (144 mg, 0.82 mmol) in 3 mL THF was added. The 
solution was warmed to 0 °C and was stirred at that temperature for additional 1 h. The 
reaction was quenched with saturated ammonium chloride solution .The organic layer was 
extracted w ith e ther (3 X lOmL) andd tied o ver MgSO^. The c rude p roduct w as flushed 
through a p ad o f  s  i l ica t  o get crude mixture of 8.  The mixture was dissolved in 4 mLof 
acetone and 0.5 mL of 2.7 M Jones reagent was added at 0 °C. After stirring at that 
temperature for 30 min quenched with 1 mL of isopropanol. Solvent was evaporated, 
dissolved in 5 mL of water and extracted with ethyl acetate (3X10 mL). Organic layer was 
dried with MgSO^ and the crude product was chromatographed on silica gel (H:EA = 5:1) to 
yield compound 8a. 300 MHz lR NMR (CDCI3) 8 12.62 (1H, s), 7.25-7.30 (3H, m), 7.15-
7.18 (2H, m), 5.51 (1H, t, J= 3.6 Hz), 4.27 (2H, q, 7.2 Hz), 3.01 (2H, d, J= 3.6 Hz), 1.32 
(3H, t, J= 7.2 Hz), 1.29 (6H, s); 75 MHz 13C NMR (CDC13) 8 175.6, 172.7, 143.6, 141.4, 
18 
129.8, 127.5, 126.7, 122.3, 93.6, 60.5, 39.86, 25.7, 25.1, 14.4. HRMS m/z for C17H20O3 calcd 
272.1412, found 272.1416. 
Compound 9 
To a solution of 2a (457 mg, 1 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of w-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and butane-
2,3-dione (70 mg, 0.82 mmol) in 3 mL THF was added. The solution was warmed to 0 °C 
and was stirred at that temperature for additional 1 h. The reaction was quenched with 
saturated ammonium chloride solution .The organic layer was extracted with ether (3X10 
mL) and dried over MgSO^. The crude product was chromatographed on silica gel (H:EA= 
4:1) to afford 9 as mixture of alcohols. 9a: 300 MHz 'H NMR (CDCI3) 8 5.49 (1H, bs), 3.12 
(2H, t, J= 6.7Hz), 2.49-2.78 (2H, m), 1.71-1.78 (3H, m), 1.49 (3H, s); 75 MHz 13C NMR 
(CDCI3) 8 144.5, 125.2, 120.5, 84.4, 42.3, 33.6, 24.8, 11.9. 9b: 300 MHz ]H NMR (CDC13) 8 
5.39 (1H, bs), 2.98 (2H, t,J= 6.7Hz), 2.49-2.78 (2H, m), 1.71-1.78 (3H, m), 1.49 (3H, s); 75 
MHz 13C NMR (CDCI3) 8 143.7, 122.9, 119.9, 83.1, 41.2, 33.5, 22.8, 11.7. HRMS m/z for 
CsHnNO calcd 137.0841, found 137.0843. 
Compound 10 
To a solution of 2a (457 mg, 1 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of w-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and 
19 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and benzil 
(172 mg, 0.82 mmol) in 3 mL THF was added. The solution was warmed to 0 °C and was 
stirred at that temperature for additional 1 h. The reaction was quenched with saturated 
ammonium chloride solution. The organic layer was extracted with ether (3 X 10 mL) and 
dried over MgSÛ4. The crude product was chromatographed on silica g el (H:EA= 3:1) to 
afford 10 as mixture of alcohols. 10a: 300 MHz *H NMR (CDCI3) 5 7.18-7.45 (10H, m), 6.45 
(1H, m), 3.38 (1H, m), 2.70-2.98 (2H, m); 75 MHz 13C NMR (CDC13) 5 146.2, 142.5, 132.9, 
129.2, 128,9, 128.6, 128.2, 127.4, 127.2, 125.4, 119.1, 87.01, 46.3, 34.2. HRMS m/z for 
CisHisNO calcd 261.1154, found 261.1156. 10b: 300 MHz 'H NMR (CDC13) 6 7.18-7.45 
(10H, m), 6.40 (1H, m), 3.58 (1H, m), 2.71-2.98 (2H, m); 75 MHz 13C NMR (CDC13) § 146.2, 
143.5, 131.9, 129.1, 128.7, 128.6, 128.1, 127.4, 127.2, 125.4, 119.1, 87.01, 45.3, 33.2. 
Compound 11 
To a solution of 2a (457 mg, 1 mmol) in 5 mL THF was added a solution of LiTMP 
generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of n-BuLi (2.5 M 
solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and stirred 
at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and fluril (162 mg, 
0.82 mmol) in 3 mL THF was added. The solution was warmed to 0 °C and was stirred at 
that temperature for additional 1 h. The reaction was quenched with saturated ammonium 
chloride solution .The organic layer was extracted with ether (3 X 10 mL) and dried over 
MgSC>4. The crude product was chromatographed on silica gel (H:EA= 4:1) to afford 11 as 
mixture of alcohols, lia: 300 MHz 'H NMR (CDCI3) 5 7.44 (1H, t, ./= 1.5 Hz), 7.35 (1H, s), 
6.39 (1H, d,J= 1.5 Hz), 6.33 (1H, d,/= 1.2Hz), 6.30 (1H, t,J= 3Hz), 3.50 (1H, t,J= 8.7 
20 
Hz), 2.84-3.00 (2H, m); 75 MHz 13C NMR (CDC13) ô 153.7, 148.1, 143.1, 142.8, 135.3, 
126.7, 118.6, 111.5, 110.9, 108.1, 107.9, 83.0, 41.9, 34.4. HRMS m/z for Ci4HnN03 calcd 
261.1154, found 261.1157. lib: 300 MHz 'H NMR (CDCI3) Ô 7.34-7.38 (2H, m), 6.40-6.53 
(1H, m), 6.34-6.40 (2H, m), 6.27-6.33 (1H, m), 5.98 (1H, t, J= 3Hz), 3.64 (1H, t, J= 8.7 Hz), 
2.98-3.02 (2H, m); 75 MHz 13C NMR (CDCI3) ô 152.7, 147.1, 143.1, 142.1, 134.3, 125.7, 
117.6, 111.5, 110.9,108.1,107.9, 83.0, 41.9, 34.4. 
Compound 12 
To a solution of 2b (457 mg, 1 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of n-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and butane-
2,3-dione (70 mg, 0.82 mmol) in 3 mL THF was added. The solution was warmed to 0 °C 
and was stirred at that temperature for additional 1 h. The reaction was quenched with 
saturated ammonium chloride solution .The organic layer was extracted with ether (3X10 
mL) and dried over MgSC^. The crude product was chromatographed on silica gel (H:EA= 
4:1) to afford 12 as mixture of alcohols. 12a: 300 MHz *H NMR (CDCI3) 8 7.15- 7.30 (10H, 
m), 6.45 (1H, m), 3.71 (2H, m), 3.57 (1H, t, /= 8.4 Hz), 2.98-3.10 (1H, m), 2.71-2.22 (1H, 
m), 0.95 (3H, t, J= 7.2 Hz). 12b: 300 MHz 'H NMR (CDC13) 5 7.15- 7.30 (10H, m), 6.43 
(1H, m), 3.61-3.78 (2H, m), 3.47 (1H, t, J= 8.4 Hz), 2.98-3.10 (1H, m), 2.71-2.22 (1H, m), 
0.95 (3H, t, J=7.2 Hz). 
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Compound 13 
To a solution of 2b (456 mg, 1 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of zz-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and 
pthalaldehyde (110 mg, 0.82 mmol) in 3 mL THF was added. The solution was warmed to 0 
°C and was stirred at that temperature for additional 1 h. The reaction was quenched with 
saturated ammonium chloride solution. The organic layer was extracted with ether (3 X 10 
mL) and dried over MgSC>4. The crude product was flushed through a pad of silica to get 
crude mixture of alcohols. The mixture was dissolved in 4 mL of acetone and 0.5 mL of 2.7 
M Jones reagent was added at 0 °C. After stirring at that temperature for 30 min quenched 
with 1 mL of isopropanol. Solvent was evaporated, dissolved in 5 mL of water and extracted 
with ethyl acetate (3X10 mL). Organic layer was dried with MgSC>4 and chromatographed 
(H:EA = 3:1) to yield compound 13. 300 MHz !H NMR (CDCI3) 6 7.98 (1H, t,J = 6 Hz), 
7.23-7.43 (10H, m), 6.57 (1H, d,J= 7.5 Hz), 6.17-6.24 (1H, m), 4.28 (2H, q, J= 7.2 Hz), 
2.60 (1H, d,J= 5.1 Hz), 1.34 (3H, t, 7=7.2 Hz). 75 MHz l3C NMR (CDCI3) 6 171.8, 167.5, 
137.7, 134.0, 133.2, 129.8, 129.7, 129.5, 128.7, 126.6, 102.0, 61.2, 21.6, 14.5 HRMS m/z for 
Q4H14O3 calcd 230.0943, found 230.0948. 
Compound 14 
To a solution of 2a (456 mg, 1 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of n-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and 
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stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and 
pthalaldehyde (110 mg, 0.82 mmol) in 3 mL THF was added. The solution was warmed to 0 
°C and was stirred at that temperature for additional 1 h. The reaction was quenched with 
saturated ammonium chloride solution. The organic layer was extracted with ether (3 X 10 
mL) and dried over MgSC>4. The crude product was flushed through a pad of silica to get 
crude mixture of alcohols. The mixture was dissolved in 4 mL of acetone and 0.5 mL of 2.7 
M Jones reagent was added at 0 °C. After stirring at that temperature for 30 min quenched 
with 1 mL of isopropanol. Solvent was evaporated, dissolved in 5 mL of water and extracted 
with ethyl acetate (3X10 mL). Organic layer was dried with MgS04 and chromatographed 
(H:EA= 3:1) to yield compound 14. 300 MHz *H NMR (CDCI3) ô 8.01 (1H, t, J = 6 Hz), 
7.23-7.43 (10H, m), 6.57 (1H, d, J= 7.5 Hz), 6.17-6.24 (1H, m), 2.6 (1H, d, J= 5.1 Hz), 
1.34( 3H, t,J= 7.2 Hz). 
Compound 16 
To a solution of 15 (458 mg, 1 mmol) in 5 mL of THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of n-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C 
and stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and 
2,3-butanedione (70 mg, 0.82 mmol) in 3 mL of THF was added. The solution was warmed 
to 0 °C and was stirred at that temperature for additional 1 h. The reaction was quenched 
with saturated ammonium chloride solution. The organic layer was extracted with ether (3 X 
10 mL) and dried over MgS04. The crude product was chromatographed on silica gel (H:EA 
= 6:1) to afford 16.300 MHz !H NMR (CDC13) ô 8.13 (1H, d, J= 8.4 Hz), 7.51-7.77 (4H, m), 
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2.68 (3H, s), 2.46 (3H, s). 
Compound 17 
To a solution of 15 (458 mg, 1 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of «-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and benzil 
(172 mg, 0.82 mmol) in 3 mL THF was added. The solution was warmed to 0 °C and was 
stirred at that temperature for additional 1 h. The reaction was quenched with saturated 
ammonium chloride solution .The organic layer was extracted with ether (3 X 10 mL) and 
dried over MgS04. The crude product was chromatographed on silica gel (H:EA = 7:1) to 
afford 17. 300 MHz 1H NMR(CDC13) 5 8.33 (1H, d,J= 8.4 Hz), 8.10 (1H, m), 7.98 (1H, d, 
J= 7.2 Hz), 7.51-7.77 (2H, m), 7.10-7.31 (10H, m). 
Compound 18: 
To a solution of 2b (457 mg, 1 mmol) in 5 mL THF at -78 °C was added a solution of 
LiTMP generated using tetramethylpiperidine (296 mg, 2.1 mmol) and 0.8 mL of n-BuLi 
(2.5 M solution in hexane) in 10 mL of THF. The solution was allowed to rise to -20 °C and 
stirred at -20 °C for a period of 90 min. The above solution was cooled to -78 °C and (105 
mg, 0.82 mmol) in 3 mL THF was added. The solution was warmed to 0 °C and was stirred 
at that temperature for additional 1 h. The reaction was quenched with saturated ammonium 
chloride solution. The organic layer was extracted with ether (3X10 mL) and dried over 
MgSC>4. The crude product was chromatographed on silica gel (H:EA = 3:1) to afford 18 as 
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mixture of alcohols: 300 MHz *H NMR (CDCI3) 6 5.24-5.39 (2H, m), 4.08-4.18 (2H, m), 
2.70-3.67 (1H, m), 2.23-2.73 (3H, m), 1.35-2.01 (6H, m), 1.31-1.35 (3H, m), 0.92-1.21 (2H, 
m). 
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CHAPTER 2 
SYNTHETIC APPROACH TOWARDS METHYLLYCACONITINE 
Introduction 
Larkspur is a toxic plant on western U.S ranges. About 5-15% of cattle poisoning on 
North American mountain lands are due to larkspur poisoning. Toxic alkaloids constitute 30-
50% of total alkaloid content in tall larkspur.1 Larkspur (Delphinium species) alkaloids can 
be divided into two structural types, namely lycactonine and 7,8-methylenedioxylycoctonine 
(deltaline) as shown in Figure 1. 
OH 
OMe ' 
OH HO' 
ÔMe ÔMe 
Lycoctonine (1) Deltaline (2) 
Figure 1. Representative alkaloids of Delphinium species. 
Among the numerous alkaloids, the lycoctonine type norditerpenoid alkaloid 
methyllycacoctonine (MLA) appears to be most toxic. Toxicity is attributed to its ability to 
act as a potent inhibitor of the acetylcholine receptor (nAChR) binding, thus leading to 
neuromuscular paralysis.2 Clinical signs include labored breathing, rapid and irregular 
heartbeat, muscular weakness and collapse.3 
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Figure 2. 
Recently, nicotinic acetylcholine receptor chemistry and biology have gained enormous 
interest in the field of drug development.4 The nAChRs are large family of ligand gated ion 
channels located throughout the body in the central nervous system, peripheral nervous 
system and at the neuromuscular junction. The family contains numerous receptor subtypes 
consisting of pentameric arrays made up from a variety of distinct peptide subunits. 
Isolation/synthesis of subtype selective agonists and antagonists could elucidate the 
biological roles of the subtypes and eventually lead to candidates for drug development. 
Pharmacological studies have shown MLA to selectively bind to the a7 subtype nAChRs in 
mammalian brain.5 The al subtype is amongst the most prevalent nAChR in the brain and 
has been implicated as playing a key role in conditions such as schizophrenia, Alzheimer's 
disease and epilepsy.6 The combined qualities of high affinity binding, functional p otency 
and subtype selectivity renders MLA as a primary lead for the development of new 
therapeutic agents targeting al nAChR. 
Structure-activity relationship investigations have indicated that the //-methyl 
succinimidobenznzoate ester at C-18 affects alkaloid interactions with nAChRs at 
neuromuscular junctions and the substituent at C-14 determines the potency and the 
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mechanism of nAChR blockade at neuromuscular synapses.7 The methyl group on the 
succinimido ring and the ethyl group of the tertiary amine were also found to be structural 
requirements for its biological activity. The pharmacological specificity of MLA seems to 
arise from the fact that the tertiary nitrogen atom of MLA and quaternary nitrogen atom of 
acetylcholine may undergo equivalent electrostatic interaction with the receptor binding site. 
Numerous Delphinium alkaloids, have been proposed as lead compounds for 
pharmaceutical research and development. Several structurally less complex analogs of MLA 
have been synthesized to establish the structural requirements necessary for biological 
activity. From the synthetic point of view, only a few partial syntheses of MLA have been 
attempted; key studies were reported by Van der Bann,8 Whiting9 and Kraus.10'11 Earliest 
work on norditerpenoid alkaloid by Van der Bann and coworkers led to an efficient 
construction of the right hand portion of the molecule, the BCDA-carbocycle part (Figure 
3).7 
O COO-f-Bu 
4 Methyllycaconitine (3) 
Figure 3. 
Synthesis of the ABCD ring system began with the efficient transformation of 1-tert-
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butoxynorbornadiene 5 to tricyclic ketone 6, which was then converted to tricyclic 
enaminoester 7. The construction of the BCD ring system was accomplished by ring 
expansion (Scheme 1) to yield compound 8. Michael additions of p-keto ester 9 to benzyl 
acrylate lead to compound 10. Cleavage of the benzyl group followed by one-carbon 
homologation and Dieckman condensation leads to the ABCD ring system. This work 
represents a solid synthesis of the right-hand portion of Cig-diterpene alkaloids skeleton. 
However, their inability to make the biologically significant E and F rings decreases the 
synthetic value of this approach. 
C02MG 
Me02C MeC>2C 
CH2=CHC02CH2Ph 
Me02C, 
Me02C Me02C 
OCH2Ph 
Scheme 1. 
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Scheme 2. 
The synthesis of ABDE ring system employing the addition reactions of bridgehead 
radicals to alkenyltributylstannanes and a,P-unsturated ketones and esters has been 
accomplished by Kraus et al.10 Initially, the bicyclic ketone 11 was reacted with allyltributyl 
in the presence of AIBN to afford the alkene 12 in good yield (Scheme 3). Ozonolysis of the 
double bond and a Wittig reaction of the resulting aldehyde yielded 13, which underwent 
Diels Alder reaction with 1 -trimethylsiloxy-l,3-butadiene. Intramolecular aldol cyclization 
with potassium hexamethyldisilazane furnished the ABDE ring system of the Cig-diterpene 
alkaloids. 
In 1998, Whitting and co-workers reported the synthesis of AEF tricyclic fragment.9 The 
stereocenters of the AEF segment were set by two key reactions: the intramolecular 1,3-
dipolar addition to the alkene and the Diels-Alder reaction. Diels-Alder reaction of the 
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sodium salt of acid 15 and acrylate 16 yielded compound 17. Compound 17 was converted to 
the isoxazolidine 19 via the nitrone in a one-pot process. Cleavage of isoxazolidine liberates 
an amine, which underwent intermolecular reaction with ester to yield the tricyclic segment 
20 as shown in Scheme 3. 
COOH 
''COOEt COOEt 
COOH 
EtNHOH/TFA 
'"COOEt 
'"COOEt 
18 19 20 
Scheme 3. 
In 1998, Kraus reported a direct route to ABE tricyclic segment (Scheme 4).11 His 
synthesis began with selective protection of enone in spirocyclic diketone 21 with 
trimethylsilyl triflate. Introduction of carbomethoxy group followed by hydrolysis yielded 
compound 22. Treatment of the compound 22 with ethylamine and formaldehyde in aqueous 
methanol furnished the tricyclic ABE segment. Unfortunately, unusual inertness of the 
carbonyl group in the one carbon bridge to a variety of nucleophiles prevented the 
elaboration of the tricylic segment to the ABEF ring system. 
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Scheme 4. 
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Results and Discussion 
In our studies towards Cig-ditepenoid alkaloids, we envisioned the synthesis of an 
ABEF ring system possessing all necessary functionality to allow us to easily incorporate the 
C and D rings. Scheme 5 suggests the synthetic strategy for the ABEF ring system. The key 
reaction is the hydrolytic skeletal rearrangement of compound 25 to aldehyde 27. Hydrolysis 
of the imine leads to an aminal 26, which should rearrange to aldehyde 27. An intramolecular 
aldol reaction could generate the required ABEF carbocycle. 
.0 
MeO-EMO 
26 25 
O I ~nn 
OMe CHO 
v 
MeO' 
OH 
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Scheme 5. 
Our first approach to intermediate 25 was from compound 24 (Scheme 6).11 Treatment 
of 24 with variety of halides led to the formation of enones 29-31. Attempts to facilitate 
intramolecular cyclization to generate the tricyclic intermediate using excess base were 
unsuccessful. Hence, an alternate strategy was conceived for the construction of ABEF ring 
system. 
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Scheme 6. 
The ABEF ring system could be envisioned from dienone 32 through hydrolytic skeletal 
rearrangement. Intramolecular /rara-C-alkylation12 of phenol 33 could lead to dienone 32. 
Keto ester 34 could act as a precursor for phenol 33. 
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32 33 
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Scheme 7. 
To test the feasibility of intramolecular cyclization, a model study was undertaken as 
shown in Scheme 8. Thus p-ketoester 3613 was reacted with the aryllithium generated from 
bromoether 36a to produce alcohol 37 as mixture of isomers. Dehydration of alcohol 36 
using thionyl chloride and subsequent removal of silyl protection from compound 38 using 
TBAF yielded phenol 39. Heating phenol 39 in ferf-butanol with 1.2 equivalents of 
potassium ferf-butoxide yielded the dienone 40 through an intramolecular spirocyclization.12 
36 
35 
OMe 1) NaH OMe 
36 
OTBS 
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58% 
OMe TBAF, 0 °C 
Quantitative 
40 39 38 
Scheme 8. 
Encouraged by the above result, our synthesis toward ABEF ring system commenced 
from known keto ester 33.14 Treatment of 33 with 2,6-lutidine and triflic anhydride yielded 
vinyl triflate 42. Suzuki coupling15 of triflate 42 with boronic acid 41 yielded compound 43 
in modest yield. The y-alkylation16 of compound 43 using LDA and HMPA furnished 
compound 44. Treatment of compound 44 with TBAF led to the removal of the TBS 
protecting group yielding phenol 33. The intramolecular cyclization was achieved using 
potassium te/Y-butoxide to yield dienone 32. 
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Scheme 9. 
With dienone in our hand we turned our attention towards the hydrolytic skeletal 
rearrangement. However, many attempts to hydrolyze carbamate 32 were unsuccessful. 
Prolonged exposure of compound 32 to acidic conditions only led to the decomposition of 32. 
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Scheme 10. 
Since hydrolysis was unsuccessful, we decided to change the protecting group on 
nitrogen to a readily-cleavable BOC group. Thus, dienone 49 was synthesized from 
carbamate 48.13 Unfortunately, our attempts to hydrolyze enone 49 were also unsuccessful, 
leading to a complex mixture. 
MeO 
CHO 
Scheme 11. 
Meanwhile, dihydroxylation of enone 32 led to isolation of phenol 51. This reaction 
occurs probably through diol 50 which undergoes a retro-aldol reaction to give 51. 
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Scheme 12. 
In order to solve the problem of hydrolysis we decided to change the order of the steps. 
Phenol 33 was converted to dithiane 52. Surprisingly, all of our attempts to facilitate the 
intramolecular cyclization only led to decomposition of starting material. 
Meanwhile, we sought to synthesize phenol 54. Reductive removal of the benzyl group 
from 55,17 followed by treatment with BOC anhydride led to compound 56. The lithium 
enolate of 56 was treated with aldehyde 57 to get the aldol adduct, which was subsequently 
oxidized with Jones reagent to get compound 58. Treatment of compound 58 with pivaloyl 
chloride and triethylamine led to the isolation of compound 59. Methyl cuprate addition to 
compound 59 led to the formation 60 in modest yield. Efforts to convert 60 to 54 were futile. 
53 
33 52 
Scheme 13. 
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Even though we were unable to synthesize the required ABEF ring system, our 
unsuccessful routes did give us some valuable insights. We learned that there is need for an 
early F ring construction. We need to introduce the required carbon appendages for F ring 
construction quite early in our synthesis. Secondly, the para-C-alkylation could be a useful 
tool for an efficient construction of the AB ring system and a simple substituted phenol could 
act as a precursor for the B ring. 
Second Generation Approach 
In spite of the failure of the approaches discussed previously, the knowledge gained 
through the previous approaches decreased the synthetic challenge considerably. Scheme 15 
gives the retrosynthesis. 
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Scheme 15 provides us an opportunity to construct the F through an aldol reaction. The 
ABE segment could be constructed from BE segment through the para-C-alkylation reaction. 
Finally, substituted 3-aminophenol could act as the B ring. 
The synthesis began from 3-aminophenol. Protection of the amino group with BOC 
anhydride followed by protection of the phenol as a TBS ether gave compound 62. 
Regioselective ort/zo-metalation18 of the aryl ring followed by treatment with excess DMF 
led to the production of aldehyde 63 as shown in Scheme 16. The BOC group acts as an 
oz-z/zo-directing group. One of the ortho positions is selectively blocked by bulky the TBS 
group, leading to selective or/Ao-metallation. The silyl ether was deprotected using TBAF to 
yield phenol 64. 
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Scheme 16. 
The phenol was converted to a MOM ether using methoxymethyl chloride and 
diisopropylethylamine to give compound 65. heating aldehyde 65 with dimethyl malonate in 
presence of piperidene led to the isolation of lactam 66 in 90% yield. This reaction occurs 
through a-p-unsaturated diester which subsequently loses the BOC protecting group to 
cyclize to the lactam 66. The Methyl group was introduced using potassium carbonate and 
ethyl iodide to give compound 67 as shown in Scheme 17. The lactam 67 represents the BE 
segment of lycoctonine alkaloid. 
43 
0HC)CX 1)TBAF Me0TY°Me «JVys 
HN ®TB®2) '-P^NEt HN^^^iDMOM Riperidine, EtO H O^^N^^^^OMOM HN 
BOC MOMCI 
87% 
BOC reflux 
89% 
65 
MeO 
Scheme 17. 
i 
H 
66 
K2C03, Etl 
83% 
Ù0CL OMOM 
67 
With the BE segment in hand, the next goal was to synthesize the ABE ring system of 
lycoctonine. However, we decided to introduce the carbon units required for the F ring at this 
stage. The carbon units required for the construction of the F ring were introduced by way of 
a vinyl unit, which could be oxidatively cleaved to an aldehyde group later in the synthesis. 
Conjugate addition of vinylcuprate (generated from vinyl magnesium bromide and copper(I) 
iodide) yielded ketoester 68 in fairly modest yield. Ultimately, vinylcuprate stabilized using 
dimethyl sulfide as the additive (entry 4, Table 1) was chosen for the conjugate addition. 
Table 1. Conjugate addition experiments 
u Vp 
k 
CT^N^^^XIMOM 
cul 
Me5S 
MeO 
60% OMOM 
67 68 
44 
Copper Source Additive % yield 
Cul None 43 
CuCN None 47 
Cul TMSC1 55 
Cul MezS 60 
None None 17 
Synthesis of the ABE segment began by steroselectively alkylating19 compound 68 
using NaH and 1, 3 -dibromopropane to yield compound 69. The as-relationship of the vinyl 
and ester groups was determined by 2D NOESY NMR. Treatment of compound 69 with 4 N 
HC1 led to the isolation of phenol 70 as shown in Scheme 18. 
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Scheme 18. 
Having achieved the synthesis of phenol 70 with the desired stereochemistry, we turned 
our attention towards the appendage of the A ring. However we were unable to effect the 
desired para-C-alkylation using standard c onditions (/-BuO"K+, Z-BuOH). F inally we were 
able to achieve the much-needed cyclization using 18-crown-6 and NaH. Heating phenol 70 
in THF with the presence of NaH and crown ether led to an intramolecular cyclization 
leading to the formation of compound 71 in modest yield as shown in Scheme 19. Compound 
71 represents the ABE segment of lycoctonine. 
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Construction of the ABEF segment required the selective oxidation of the terminal 
double bond in the presence of enone as shown in Scheme 20. Unfortunately, we were unable 
to oxidize the terminal double bond selectively. We decided on a detour as shown in Scheme 
21. 
MeO' MeO' 
O 
CHO Selective Oxidation 
MeO' 
OH 
Scheme 20. 
Ozonolysis of compound 69 gave an aldehyde in 92% yield. Treatment of the aldehyde 
with timethylorthofonnate in methanol with the presence of a catalytic amount of PTSA led 
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to the protection of the aldehyde as a dimethyl acetal with a subsequent removal o f the 
MOM group to liberate phenol 73 in 62% yield. Heating phenol 73 in THF in the presence of 
NaH and crown-ether led to an intramolecular cyclization leading to the formation of ABE 
segment of lycoctonine as shown in Scheme 21. 
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Scheme 21. 
Having constructed the ABE ring system (compound 74), we went towards the addition 
of the F ring. Surprisingly, the reduction of dienone proved difficult. Hydrogénation of the 
dienone led to the reduction of only the less hindered double bond. Use of reducing agents 
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like Zn/acetic acid20 and K-selectride21 led to the isolation of complex mixtures. Finally, we 
were able to reduce the enone double bond using Li/NH322 along with concomitant reduction 
of the ester group to an aldehyde to yield compound 76 as shown in Scheme 22. 
H2 / Pd, EtOAc 
Li, NH3, t-buOH/THF 
Oxidation 
MeO 
3:1 mixture 
Scheme 22. 
Having achieved our 1,4-reduction, we tried converting the tricyclic intermediate 76 to 
the ABEF ring system. Attempts to do an intramolecular aldol reaction under acidic 
conditions led to the decomposition of the ketoaldehyde. We attributed the failure of this 
reaction to the aldehyde group present in the molecule. Surprisingly, we were unable to 
oxidize the sterically hindered aldehyde. Hence, we turned our attention to a selective 
reduction. Hydrolysis of the methyl ester using LiOH gave acid 77 in modest yield. Li/NHa 
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reduction of the acid led to selective reduction of the enone to yield acid 78, which was 
treated with diazomethane to yield methyl ester 79 as 3:1 mixture of isomers. The major 
isomer was crystallized and its structure was confirmed using X-ray crystallography. 
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Treatment of compound 79 with 4N HC1 led to the isolation of compound 80 in 58% 
yield plus 17% of ketoaldehyde 81 arising from the minor isomer. Compound 80 represents 
the ABEF carbocycle of methyllycaconitine as shown in Scheme 24. 
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Compound 80 was elaborated to enone 84 as shown in Scheme 25. Treatment of 
compound 80 with CSA and /«ara-methoxybenzylacetamidate23 gave compound 82. The silyl 
enol ether (generated using LDA, and TMSCl) of 82 was converted to enone 83 using 
Pd(OAc)2,24 
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The enone 84 represents the ABEF carbocycle skeleton of the aconitine alkaloids with 
all the functionality necessary to install the C and D rings as shown in Scheme 26. Finally, 
the biologically significant 2-methylsuccinimido benzoate ester on the C19 neopentyl alcohol 
would be introduced to yield the core structure of MLA. 
52 
MeO' 
OPMB 
MeO MeO 
OPMB OPMB 
I Y X°H 
y I OH 
MeO 
Hexacyclic Core Structure of Lycoctonine 
Me 
(V°o® 
)=0 
o \ Z 
MsO 
MeO 
Scheme 26. 
o 
Core Structure of M LA 
Recently a novel C2o-diterpenoid alkaloid was isolated from Aconitum racemulosum.25 
To test the generality of our approach we synthesized the ABE segment of this alkaloid as 
shown in Scheme 27. 
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Alkylating compound 68 using NaH and 1,3-dibromoethane afforded compound 85. 
Treatment of compound 85 with 4N HCl led to the isolation of phenol 86 which was 
subsequently transformed to the ABE segment of racemulosomine using NaH and 18-crown-
6. 
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In conclusion, we developed a direct synthetic route to ABEF segment of 
methyllycaconitine using intramolecular anionic spiro cyclization. Construction of the ABE 
segment of methyllycaconitine and racemulosine through a common bicyclic intermediate 
was achieved. Elaboration of the ABEF segment of lycoctonine alkaloid to the pentacyclic 
intermediate is under progress. 
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Experimental Section 
Unless otherwise noted, materials were obtained from commercial suppliers and used 
without purification. Tetrahydrofuran was distilled from sodium benzophenone ketyl. 
Dichloromethane and benzene were distilled over calcium hydride. All experiments were 
performed under argon atmosphere unless otherwise noted. Nuclear magnetic resonance 
experiments were performed with either a Varian 300 MHz or Broker 400 MHz instrument. 
All chemical shifts are reported relative to CDCI3 (7.26 ppm for 'H and 77.06 ppm for 13C), 
unless otherwise noted. Coupling constants (J) are reported in Hz with abbreviations: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet. High resolution mass spectra were 
recorded on a Kratos model MS-50 spectrometer and low resolution mass spectra were 
performed with a Finnegan 4023 mass spectrometer. Standard grade silica gel (60 A0, 32-63 
jj.m) was used for a flash column chromatography. 
Compound 29 
A mixture of 24 (100 mg, 0.326 mmol) and 1 mL 2-bromomethyl acetate were heated at 
60 °C for 24 h. The mixture was concentrated in vacuo, the residue was diluted with ethyl 
acetate and washed with brine. The organic layer was dried over MgSC>4, filtered, and 
evaporated in vacuo. The residue was purified by chromatography (H:EA - 1:1) to afford 
compound 29 (85 mg, 69%). 300 MHz *H NMR (CDCI3) § 7.07 (1H, d, J = 10.2 Hz) , 6.04 
(1H, d, J= 10.2 Hz), 4.29-4.25 (2H, m), 3.83 (3H,s), 3.59 (1H, d, J= 12.3 Hz), 3.2-3.3 (2H, 
m), 3.04 (1H, J= 12.3 Hz), 2.6-2.7 (1H, d, J = 15 Hz), 2.3-2.5 (4H, m), 1.8-2.2 (5H, m), 1.5 
(3H, t, /= 7.2Hz), 1.3 (3H, t, J= 9Hz). 
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Compound 30 
A mixture of 24 (100 mg, 0.326 mmol) and 1 mL 2-bromoacetonitrile was heated at 60 
°C for 36 h. The mixture was concentrated in vacuo, the residue was diluted with ethyl 
acetate and washed with brine. The organic layer was dried over MgSC>4, filtered, and 
evaporated in vacuo. The residue was purified by chromatography (H:EA = 1:1) to afford 30 
(80mg, 71%). 300 MHz *H NMR (CDC13) 8 6.7 (1H, d,J = 10.2 Hz), 6.08 (1H, d,J= 10.2 
H z ) ,  4 . 1 - 4 . 3  ( 2 H ,  m ) ,  3 . 8 3  ( 3 H , s ) ,  3 . 6 1  ( 1 H ,  d  , J =  1 2 . 3  H z ) ,  3 . 2 - 3 . 3  ( 2 H ,  m )  3 . 0 4  ( 1 H ,  J  =  
12.3 Hz), 2.6-2.7 (1H, d, J= 15 Hz), 2.3-2.5 (4H, m), 1.8-2.2 (5H, m), 1.5 (3H, t, J=6.9Hz). 
Compound 31 
A mixture of 24 (100 mg, 0.326 mmol) and 1 mL ethylbromomethyl phosphonate were 
heated at 60 °C for 36 h. The mixture was concentrated in vacuo, the residue was diluted with 
ethyl acetate and washed with brine. The organic layer was dried over MgSC>4, filtered, and 
evaporated in vacuo. The residue was purified by chromatography (H:EA = 3:1) to afford 31 
(97 mg, 65%).300 MHz !H NMR (CDC13) Ô 6.70 (1H, d, /= 10.2 Hz), 6.08 (1H, d, /= 10.2 
H z ) ,  4 . 1 0 - 4 . 3 0  ( 6 H ,  m ) ,  3 . 8 1 - 3 . 9 5  ( 2 H ,  m )  3 . 8 3  ( 3 H , s ) ,  3 . 6 1 ( 1 H ,  d , J =  1 2 . 3  H z ) ,  3 . 0 4  ( 1 H ,  J  
= 12.3 Hz), 2.60-2.70 (1H, d, ./= 15 Hz), 2.3-2.5 (4H, m), 1.8-2.2 (5H, m), 1.50-165 (9H, m). 
Compound 37 
To a solution of ether 36 (173 mg, 0.60 mmol) in THF (10 mL) at -78 °C was added 
2.42 mL of w-BuLi (2.5 M in hexanes, 0.6 mmol). After 30 min at that temperature, a solution 
of bromide 36a (168 mg, 0.58 mmol) in 1 mL THF was added dropwise. The reaction 
mixture was gradually warmred to rt and quenched with saturated NH4CI. The organic 
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solvent was evaporated in vacuo. The residue was diluted with ethyl acetate and washed with 
brine. The organic layer was dried over MgSC>4, filtered, and evaporated in vacuo. The 
residue was purified by chromatography (H:EA= 4:1) to afford 37 as mixture of isomers 
( 2 5 5  m g ,  8 5  %  y i e l d ) .  3 0 0  M H z  ' H  N M R  ( C D C 1 3 )  8  7 . 3 7  ( 2 H ,  d , J =  8 . 7  H z ) ,  7 . 1 2  ( 2 H ,  d ,  J  
= 8.7 Hz), 3.90-4.20 (2H,m), 3.30-3.50 (2H, m), 2.10-2.40 (4H,m), 1.20-2.0 (8H, m), 1.22 
(3H, t,J= 6.9 Hz), 0.90 (9H, s), 0.21 (6H, s). 
Compound 38 
To a solution of alcohol 37 (163mg, 0.32 mmol) in 0.5 mL of pyridine at 0 °C was added 
116 mg (0.978 mmol) of SOCI2. After being stirred at 0 °C for 45 min 2 mL of ice cold water 
was poured into the reaction mixture. The organic layer was extracted with ethyl acetate (3 X 
5 mL) and dried over MgSC>4, filtered, and evaporated in vacuo. The residue was purified by 
chromatography (H:EA = 4:1) to afford 38 (92mg, 60%). 300 MHz 'H NMR (CDCI3) 8 6.99 
(2H, d, J = 8.4 Hz), 6.71 (2H, d, J = 8.4 Hz), 5.94 (1H, t, J = 4.8Hz), 4.12-4.20 (2H, m), 
3.07-3.11 (2H, m), 2.10-2.30 (2H, m), 1.80-2.10 (2H, m), 1.50-1.80 (6H, m), 1.24 (3H, t, J = 
7.2 Hz), 0.96 (9H, s), 0.18 (6H, s). 
Compound 39 
To a solution of 39 (61 mg, 0.127 mmol) in THF (3 mL) at 0 °C was added 130 jiL of 
TBAF ( 1M in THF). The reaction mixture was stirred at that temperature for 30 min and 
quenched with saturated NH4CI. The organic solvent was evaporated in vacuo. The residue 
was diluted with ethyl acetate and washed with brine. The organic layer was dried over 
MgSC>4, filtered, and evaporated in vacuo. The residue was purified by chromatography 
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(H:EA= 2:1) to afford 39 (46 mg, quantitative yield). 300 MHz !H NMR (CDCI3) S 7.11 (2H, 
d,J= 8.7 Hz), 6.79 (2H, d, J= 8.7 Hz), 6.01 (1H, t, 7 = 4.8Hz), 4.12-4.20 (2H, m), 3.00-3.11 
(2H, m), 2.10-2.40 (2H, m), 1.80-2.10 (2H, m), 1.50-1.80 (6H, m), 1.25 (3H, t,J= 7.2 Hz). 
Compound 40 
To a solution of 39 (37 mg, 0.1 mmol) in 10 mL freshly distilled f-BuOH at room 
temperature was added f-BuOK (13 mg, 0.11 mmol). The above solution was refluxed under 
argon for 24 h. The reaction mixture was cooled to room temperature and then quenched with 
1 mL of saturated NH4CI. The organic solvent was evaporated in vacuo. The residue was 
diluted with ethyl acetate and washed with brine. The organic layer was dried over MgSC>4, 
filtered, and evaporated in vacuo. The residue was purified by chromatography (H:EA - 2:1) 
to afford 40 (17 mg, 58 % yield). 300 MHz 'H NMR (CDC13) 5 7.07 (1H, d,J = 10.2 Hz), 
6 . 8 9  ( 1 H ,  d , J =  1 0 . 2  H z ) ,  6 . 2 6  ( 1 H ,  d ,  J =  1 0 . 2  H z ) ,  6 . 0 9  ( 1 H ,  d , J =  1 0 . 2  H z ) ,  5 . 6 9  ( 1 H ,  t ,  J  
= 3.6 Hz), 4.16-4.24 (2H, m), 2.53 (1H, d,J= 13.2 Hz), 2.01-2.10 (3H, m), 1.63-1.74 (4H, 
m), 1.42-1.58 (4H, m), 1.26 (3H, t, J= 7.2 Hz); 75 MHz 13C NMR (CDCI3) Ô 186.6, 176.4, 
156.4, 153.3, 135.6, 129.3, 128.1, 125.5, 61.3, 46.9, 46.4, 37.6, 36.4, 36.2, 25.9, 19.4, 18.5, 
14.4. 
Compound 42 
To a suspension of KH (197 mg, 4.49 mmol) in 10 mL of THF at 0 °C was added a 
solution of ketoester 34 (900 mg, 4.47 mmol) in THF (45 mL). After 30 min, FhN(Tf)^ (1.92 
g, 5.36 mmol) was added at 0 °C in one portion. The reaction mixture was stirred at rt for 4 h. 
The mixture was diluted with petroleum ether and flushed through a pad of silica gel. The 
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filtrate was concentrated in vacuo to afford 42 (895 mg, 62% yield) 300 MHz 'H NMR 
(CDC13) 5 7.4 (2H, d,J = 7.2 Hz), 6.80 (2H, d,J = 7.2 Hz), 4.40-4.60 (4H, m), 3.73 (3H, s), 
3.66 (3H, s). 
Compound 44 
A solution of 42 (1.51 g, 4.68 mmol) in toluene (60 mL) was treated with Pd(PPh3 )3 
(540 mg, 0.468 mmol), boronic acid 43 (1.3 g, 5.15 mmol), K2CO3 (970 mg, 7.02 mmol) and 
H2O (2 mL). The reaction was boiled for 12 h at 85 °C. After cooling the reaction mixture, it 
was partioned with ethyl acetate and sat. Na2CC>3. The combined organic layers were dried 
over MgSCU, filtered, and evaporated in vacuo. The residue was purified by chromatography 
(H:EA = 3:1) to afford 44 (1.55 g, 85%) as a yellow oil. 300 MHz *H NMR (CDC13) 6 7.32 
(2H, d,J= 1.2 Hz), 6.81 (2H, d,J = 7.2 Hz), 4.50-4.70 (4H, m), 3.71 (3H, s), 3.66 (3H, s), 
0.94 (9H, s), 0.21 (6H, s). 
Compound 45 
To a solution of diisopropylamine (298 pL, 2.13 mmol) in THF (10 mL) was added n-
BuLi (2.5 M solution in hexanes, 850 jj,L, 2.12 mmol) at -78 °C. After 15 min at 0 °C, the 
solution was taken back to -78 °C and hexamethylphosphoric triamide (435 pL, 2.5 mmol) 
was added. A solution of compound 44 (750 mg, 1.97 mmol) in 20 mL of THF was slowly 
transferred to the mixture at -78 °C via cannula. After 30 min 1,3-dibromopropane (486 pL, 
4.79 mmol) was added to reaction mixture. After being gradually warmed up to rt, the 
mixture was quenched with^O. The mixture was diluted with ethyl acetate and washed 
with brine. The organic layer was dried over MgS04, filtered, and evaporated in vacuo. The 
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residue was purified by chromatography (H:EA = 5:1) to give 45 (569 mg, 58%). 300 MHz 
'H NMR (CDC13) 5 7.11 (2H, d. J= 8.7 Hz), 6.96 (1H, s), 6.74 ( 2H, d, J = 8.7 Hz), 4.10-
4.20 (2H, m), 3.82 (3H, s), 3.72 (3H, s), 3.31 (2H, t,J= 6.6 Hz ), 1.71-2.08 (4H, m), 0.96 
(9H, s), 0.18 (6H, s). 
Compound 33: 
To a solution of 45 (400 mg, 0.97 mmol) in THF (3 mL) at 0 °C was added 1 mL of 
TBAF (1M in THF). The reaction mixture was stirred at that temperature for 30 min and 
quenched with saturated NH4CI. The organic solvent was evaporated in vacuo. The residue 
was diluted with ethyl acetate and washed with brine. The organic layer was dried over 
MgSC>4, filtered, and evaporated in vacuo. The residue was purified by chromatography 
(H:EA = 2:1) to afford 33 (385 mg, Quantitative yield ). 300 MHz 'H NMR (CDC13) Ô 7.15 
(2H, d. J - 8.7 Hz), 6.96 (1H, s), 6.75 (2H, d,J= 8.7 Hz), 4.18-4.21 (1H, m), 3.82 (3H, s), 
3.79-3.83 (1H, m), 3.72 (3H, s), 3.31 (2H, t,J= 6.6 Hz ), 2.03-2.13 (2H, m), 1,82-1.88 (1H, 
m), 1.78-1.82 (lH,m). 
Compound 32: 
To a solution of 33 (370 mg, 0.92 mmol) in 90 mL freshly distilled f-BuOH at rt was 
added f-BuOK (130mg, 1.1 mmol). The above solution was refluxed under argon for 24 h. 
The reaction mixture was cooled to room temperature and then quenched with 1 mL of 
saturated NH4CI. The organic solvent was evaporated in vacuo. The residue was diluted with 
ethyl acetate and washed with brine. The organic layer was dried over MgSCU, filtered, and 
evaporated in vacuo. The residue was purified by chromatography (H:EA = 2:1) to afford 32 
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(180 mg, 63%). 300 MHz *H NMR (CDC13) ô 6.93 (1H, d, J =  10.2 Hz), 6.82 (1H, d, J =  9.9 
Hz), 6.42 (1H, s), 6.37 (1H, d, J= 9.9 Hz), 6.17 (1H, d, J= 10.2 Hz), 4.07-4.15 (1H, m), 3.73 
(6H, s), 3.55-3.59 (1H, m), 2.65-2.71 (1H, m), 1.76-1.91 (2H, m), 1.64-1.69 (2H, m), 1.42-
1.49 (1H, m); 75 MHz 13C NMR (CDC13) 8 186.8, 172.3, 155.1, 153.8, 153.2, 130.6, 127.8, 
126.9, 58.3, 52.8, 52.1, 51.5, 50.3, 37.3, 32.8, 19.5. HRMS m/z for C17H19NO5 calcd 
317.1342, found 317.1311. 
Compound 49 
300 MHz !H NMR (CDC13) 8 6.91 (1H, d, J =  10.2 Hz), 6.72 (1H, d, J =  9.9 Hz), 6.45 
(1H, s), 6.31 (1H, d, J- 9.9 Hz), 6.05 (1H, d, J= 10.2 Hz), 4.07-4.15 (1H, m), 3.73 (3H, s), 
3.55-3.59 (1H, m), 2.65-2.71 (1H, m), 1.76-1.91 (2H, m), 1.64-1.69 (2H, m), 1.42-1.49 ( 1H, 
m), 1.23 (9H,s). 
Compound 51 
To a solution 32 (15 mg, 0.047 mmol) in f-Bu0H/THF/H20 (1 mL/0.5 mL/0.3 mL) was 
added 7 mg (0.052 mmol) of NMO and 0.26 mL of OSO4 (0.005mmol) solution (5mg/mL). 
The mixture was stirred at room temperature for 3 h and quenched with saturated NH4CI. 
Diluted with ethyl acetate and the organic layer washed with brine. The organic layer was 
dried over MgSC>4, filtered, and evaporated in vacuo. The residue was purified by 
chromatography (H:EA = 2:1) to afford 51 (10 mg, 60% yield). 300 MHz *H NMR (CDCI3) 
8 6.97 (2H, d, J - 8.4 Hz), 6.73 (2H, d,/= 8.4 Hz), 5.22 (1H, bs), 4.13-4.20 (1H, m), 3.79 
(3H, s), 3.65 (3H, m), 3.62-3.68 (1H, m), 2.52 (2H, t, J= 7.2 Hz), 1.40-1.81 (4H, m). 
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Compound 52 
To a solution of compound 32 (28 mg, 0.088 mmol) in 3 mL CH2CI2 was added 12.3 jjL 
BF3:Et20 and 9.7 pL propane-1,3-dithiol at 0 °C. The reaction was raised to room 
temperature and stirred at that temperature for 16 h, quenched with saturated NH4CI, diluted 
with ethyl acetate and the organic layer washed with brine. The organic layer was dried over 
MgSC>4, filtered, and evaporated in vacuo. The residue was purified by chromatography 
(H:EA= 3:1) to afford 52 (19 mg, 45%) as a mixture of isomers. 300 MHz 'H NMR (CDCI3) 
5 7.05 (2H, d,J= 8.4 Hz), 6.85 (2H, d,J= 8.4 Hz), 5.22 (1H, m), 4.13-4.20 (1H, m), 3.80-
4.01 (4H, m) 3.79 (3H, s), 3.62-3.68 (2H, m), 3.32 (2H, m), 1.40-1.80 (6H, m). 
Compound 58 
To a solution of diisopropylamine (461 pL, 3.3 mmol) in THF (15 mL) was added n-
BuLi (2.5 M solution in hexanes, 1.3 mL, 3.2 mmol) at -78 °C. After 15 min at 0 °C, the 
solution was cooled to -78 °C and a solution of compound 55 (690 mg, 3 mmol) in 5 mL THF 
was added slowly to the mixture. After 20 min, a solution of 57 (792 mg, 3.6 mmol) in THF 
(2 mL) was slowly added to this mixture at -78 °C and the mixture was allowed to raise to 
room temperature and quenched with saturated NH4CI. The organic solvent was evaporated 
in vacuo. The residue was diluted with ethyl acetate and washed with brine. The organic 
layer was dried over MgSC>4, filtered, and evaporated in vacuo. The crude mixture was 
dissolved in acetone (10 mL) and 2.0 mL of Jones reagent was added to the reaction mixture 
at 0 °C. After stirring at that temperature for 45 min, 2 mL isopropanol was added to quench 
the reaction. The organic solvent was evaporated and the residue was diluted with saturated 
ammonium chloride. The aqueous layer was extracted with ethyl acetate. The organic layer 
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was dried over MgSC>4, filtered, and evaporated in vacuo. The residue was purified by 
chromatography (H:EA = 4:1) to afford 58 (1.19g, 89 % yield). 300 MHz *H NMR (CDCI3) 
8 7.97 (2H, d,J = 8.4 Hz), 6.87 (2H, d,J= 8.4 Hz), 3.74-3.80 (2H, m), 3.66 (3H, s), 3.67-
3.72 (1H, m), 3.12-3.29 (2H, m), 1.43 (9H, s), 1.10-1.20 (3H, m), 0.91 (9H, m), 0.22 (6H, s). 
Compound 59 
To a solution of compound 58 (640 mg, 1.42 mmol), in 5 mL HMPA was added 575 mg 
(5.68 mmol) triethylamine and 667 mg (5.53 mmol) pivaloyl chloride. The above mixture 
was allowed to stir at rt for 24 h. The reaction mixture was poured into half saturated NaCl 
solution, extracted with ethyl acetate. The organic layer was dried over MgSC>4, filtered, and 
evaporated in vacuo. The residue was purified by chromatography (H:EA = 4:1) to afford 59 
(580 mg, 81%). 300 MHz :H NMR (CDCI3) 8 7.36 (2H, d,J= 8.4 Hz), 7.05 (2H, d,J= 8.4 
Hz), 4.18-4.28 (2H, m), 3.54 (3H, s), 3.27-3.34 (2H, m), 1.45 (9H, s), 1.33 (9H, s), 1.21 (9H, 
s), 1.10 (3H, t, J = 7.2 Hz). 
Compound 60 
To a suspension of Cul (96.55 mg, 0.506 mmol) in 3 mL THF at -78 °C was added 0.75 
mL MeLi (1.4 M in THF). The mixture was brought up to 0 °C and stirred at that temperature 
for 15 min. The above mixture was taken back to -78 °C and a solution of 59 (203 mg, 0.41 
mmol) in 5 mL of THF was cannulated to the reaction mixture. After stirring at -78 °C for 1 h, 
the temperature was gradually raised to 0 °C. The reaction was quenched with saturated 
NH4CI and extracted with ethyl acetate. The organic layer was dried over MgSCU, filtered, 
and evaporated in vacuo. The residue was purified by chromatography (H:EA = 3:1) to afford 
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60 (144 mg, 85 %). 400 MHz !H NMR (CDC13) 8 7.12 (2H, d, J = 8.4 Hz), 7.03 (2H, d,J = 
8.4 Hz), 3.99 (2H, s), 3.77 (3H, s), 3.12-3.23 (2H, m), 2.11 (3H, s), 1.32 (9H, s), 1.30 (9H, s), 
1.06 (3H, t, J= 1.2 Hz). 
Compound 62 
To a solution of 3-aminophenol (12.0 g, 110 mmol) in 250 mL f-BuOH was added di-Z-
butyldicarbonate (24 g, 110 mmol). The above mixture was heated at 80 °C for 23 h. The 
solvent was evaporated and the residue was dissolved in 300 mLof CH2CI2. The organic 
layer was washed with brine, dried and evaporated to give protected phenol which was taken 
directly to the next step. The crude mixture was dissolved in 200 mL of DMF. I midazole 
(10.02 g, 165 mmol) and TBSC1 (16.85 g, 110 mmol) was added and the reaction mixture 
was stirred at room temperature for 12 h. The mixture was poured into half saturated NaCl 
solution, extracted with ethyl ether. The organic layer was dried over MgSCU, filtered, and 
evaporated in vacuo. The residue was purified by chromatography (H:EA = 2:1) to afford 62 
(32.6 g, 92%). 400 MHz 'H NMR (CDC13) 8 7.12 (1H, t, J= 8 Hz), 6.88 (1H, d,J = 8Hz), 
6.85 (1H, s), 6.49 (1H, d, J= 8 Hz), 6.39 (1H, s), 1.49 (9H, s), 0.95 (9H, s), 0.18 (6H, s). 
Compound 63 
To solution of 62 (10 g, 31 mmol) in 300 mL ethyl ether was degassed for 20 min and 
cooled to -78 °C. To the above solution 46 mL f-BuLi (1.7 M solution in pentane) was added 
and temperature was gradually brought up to -40 °C. After stirring at this temperature for 2 h, 
the mixture was taken back to -78 °C. 10 mL DMF was added and the reaction mixture was 
gradually warmed to 0 °C. The mixture was quenched with saturated NH4CI and mixture was 
65 
poured into 100 mL of water and extracted with ether. The combined ether extracts was 
washed with brine, dried and evaporated under reduced pressure to give 63, 400 MHz *H 
NMR (CDC13) 6 10.45 (1H, s), 9.66 (lH,s), 7.93 (1H, s), 7.39 (1H, d, J= 8.4Hz), 6.70 (1H, d, 
J= 8.4Hz), 1.49 (9H, s), 0.96 (9H, s), 0.19 (6H, s). 
Compound 64 
The crude mixture of 63 was dissolved in 100 mL of THF. 30 mL of TBAF (1M solution 
in THF) was added at 0 °C. After stirring at that temperature for 30 min the reaction was 
quenched with saturated NH4CI .The mixture was poured into 60 mL of water and extracted 
with ethyl acetate. The combined organic extracts was washed with brine, dried and 
evaporated under reduced pressure. The crude product was purified by chromatography 
(H:EA = 2:1) to give 64 (4.92 g, 69 % yield over two steps). 400 MHz 'H NMR (CDCI3) Ô 
10.66 (1H, s), 9.69 (1H, s), 7.94 (1H, s), 7.70 (1H, s), 7.49 (1H, d, J= 8.4 Hz), 6.61 (1H, d, J 
= 8.4 Hz), 1.52 (9H, s); 75 MHz 13C NMR (CDCI3) Ô 193.3, 163.5, 153.8, 143.9, 139.2, 
115.6, 110.3, 104.8,81.9, 28.5. 
Compound 65 
To a solution of 64 (5.00 g, 21.5 mmol) in 300 mL CH2CI2 was added 11.3 mL of di-
isopropylethylamine (64.5 mmol). The mixture was cooled to 0 °C and 3.26 mL MOMC1 was 
added slowly. The mixture was warmed to room temperature and stirred at that temperature 
for 8 h. The mixture was diluted with 100 mL CH2CI2 and the organic layer was washed with 
saturated NaHCC>3 and brine. The organic extracts were dried over MgSCU, filtered, and 
evaporated in vacuo. The residue was purified by chromatography (H:EA = 5:1) to afford 65 
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(5.13 g, 85% yield). 300 MHz 'H NMR (CDC13) §10.52 (1H, s), 9.66 (1H, s), 8.06 (1H, s), 
7.46 (1H, d,J= 8.4 Hz), 6.69 (1H, d, J= 8.4 Hz), 5.19 (2H, s), 3.44 (3H, s), 1.52 (9H, s); 100 
MHz l3C NMR (CDCI3) 8 193.4, 163.5, 153, 144.1, 138.45, 116.4, 109.64, 105.1,94.2, 81.2, 
56.7, 28.4. 
Compound 66 
To a solution of 65 (4.00 g, 14.2 mmol) in 25 mL methanol was added 
dimethylmalomate (5.63 g, 42.6 mmol) and piperidine (604 mg, 7.1 mmol). The mixture was 
refluxed for 24 h. The reaction mixture was cooled to room temperature and the organic 
solvents were evaporated to give solid residue. The solid residue was washed with 
hexane/ethyl ether (3:1) mixture and filtered to get pure 66 as a white solid (3.89 g, 90% 
yield). 300 MHz *H NMR (CDC13) 8 8.41 (1H, s), 7.75 (1H, d,J= 8.4Hz), 7.10 (1H, s), 6.94 
(1H, s), 5.36 (2H, s), 3.80 (3H, s), 3.45 (3H, s). 
Compound 67 
To a solution of compound 66 (3.6 g, 13 mmol) in 250 mL of acetone was added K2CO3 
(10 g, 104 mmol) and ethyl iodide (6.84 g, 39 mmol). After being refluxed under argon for 15 
h, the mixture was filtered and organic solvent was evaporated in vacuo. The residue was 
diluted with ethyl acetate and washed with brine. The organic layer was dried over MgSO-i, 
filtered, and evaporated in vacuo. The residue was purified by chromatography (EA:CHzCl2 
= 1:1) to afford 67 (3.21 g, 85%). 300 MHz 'H NMR (CDCI3) 8 8.41 (1H, s), 7.71 (1H, d, J= 
8.4Hz), 7.02 (1H, s), 6.94 (1H, s), 5.36 (2H, s), 4.27 (2H, q, J= 7.2 Hz), 3.80 (3H, s), 3.45 
(3H, s), 1.21 (3H, t, J =7.2 Hz). 
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Compound 68 
To a suspension of Cul (2.29 g, 12 mmol) in 25 mL of THF at -78 °C was added 3 mL of 
dimethyl sulfide and 24 mL of vinylmagnesium bromide (1 M solution in THF). The mixture 
was brought up to 0 °C and stirred at that temperature for 15 min. The above mixture was 
taken back to -78 °C and a solution of 67 (1.85 g, 6 mmol) in 75 mL of THF was cannulated 
to the reaction mixture. After stirring at -78 °C for 1 h, the temperature was gradually raised 
to 0 °C. The reaction was quenched with saturated NH4CI and extracted with ethyl acetate. 
The organic layer was dried over MgSCX filtered, and evaporated in vacuo. The residue was 
purified by chromatography (H:EA = 5:1) to afford 68 (1.19 g , 60 % yield). 300 MHz *H 
NMR (CDCI3) 5 7.11 (1H, d, / = 8.4 Hz), 6.71-6.79 (2H, m), 5.78 (1H, dt, J = 12 Hz,J = 
8Hz), 5.21 (1H, d,J= 8 Hz), 5.18 (2H, s), 5.06 (1H, d,J= 12 Hz), 3.88-4.09 (3H, m), 3.68 
(3H, s), 3.52 (1H, d,J= 7.4 Hz), 3.49 (3H, s), 1.26 (3H, t, J= 7.2 Hz); 100 MHz 13C NMR 
(CDCI3) ô 169.0, 164.9, 157.5, 138.9, 136.2, 128.9, 119.0, 118.2, 109.9, 94.5, 55.95, 53.4, 
52.2, 42.7, 37.6, 12.3. 
Compound 69 
To a suspension of NaH (90 mg, 3.6 mmol) in 5 mL of THF was added a solution of 
compound 68 (1.01 g, 3.05 mmol) in 25 mL of THF at 0 °C. After stirring for 20 min, HMPA 
(530 |iL, 3.06 mmol) and 1,3-dibromopropane (1.81 g, 9 mmol) was added. The mixture was 
refluxed for 16 h the reaction was quenched with saturated NH4CI. The mixture was poured 
into 10 mLof water and extracted with ethyl acetate. The combined organic extracts was 
washed with brine, dried and evaporated under reduced pressure. The crude product was 
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purified by chromatography (H:EA = 4:1) to give 69 (1.02 g, 79%). 300 MHz *H NMR 
(CDC13) 5 6.99 (1H, d,J = 8.4 Hz), 6.66-6.72 (2H, m), 6.13 (1H, dt, J = 12 Hz, J = 8Hz), 
5.38 (1H, d, J 8 Hz), 5.21 (1H, d, J= 12Hz), 5.14 (2H, s) 4.02-4.18 (1H, m), 3.78-3.89 (1H, 
m), 3.49 (3H, s), 3.42 (1H, d, J= 7.4 Hz), 3.35 (3H, s), 3.38-3.48 (2H, m), 2.01-2.19 (2H, m), 
1.84-1.93 (2H, m), 1.26 (3H, t, J =1.2 Hz). 
Compound 70 
To a solution of 69 (450 mg, 1.03 mmol) in 10 mL of ethyl acetate at 0 °C was added 1 
mL of 4 N HCl. The reaction mixture was stirred at that temperature for 30 min. Diluted with 
ethyl acetate (10 mL) and washed with 10% NaHCO; solution and brine. The organic layer 
was dried over MgSCU, filtered, and evaporated in vacuo. The residue was purified by 
chromatography (H:EA = 2:1) to afford 70 (400 mg, Quantitative yield). 300 MHz *H NMR 
( C D C I 3 )  ô  6 . 9 7  ( 1 H ,  d , /  =  8 . 4  H z ) ,  6 . 6 0  ( 1 H ,  s ) ,  6 . 5 2  ( 1 H ,  d , J =  8 . 4  H z ) ,  6 . 1 5  ( 1 H ,  d t , J  =  
12 Hz, J= 8Hz), 5.41 (1H, d,/=8 Hz), 5.25 (1H, d, J = 12Hz), 4.08-4.18 (1H, m), 3.81-
3.92 (1H, m), 3.51 (3H, s), 3.47 (1H, d, J= 7.4 Hz), 3.41-3.52 (2H, m), 2.01-2.19 (2H, m), 
1.84-1.93 (2H, m), 1.26 (3H, t,J= 7.2 Hz); 100 MHz 13C NMR (CDCI3) ô 170.65, 167.4, 
157.3, 139.0, 134.2, 127.8, 120.2, 109.7, 103.6, 94.6, 56.1, 52.1, 47.3, 38.4, 33.6, 31.6, 27.6, 
12.1 
Compound 71 
To a suspension of NaH (29 mg, 1.2 mmol) in 5 mL of THF was added a solution of 
compound 70 (390 mg, 1.00 mmol) in 10 mL of THF at 0 °C. After stirring for 20 min, 18-
crown-6 (270 mg, 1.02 mmol) and 80 mL of THF was added and the reaction mixture was 
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refluxed for 24 h under argon. The reaction mixture was cooled to room temperature and then 
quenched with 1 mL of saturated NH4CI. The organic solvent was evaporated in vacuo. The 
residue was diluted with ethyl acetate and washed with brine. The organic layer was dried 
over MgSC>4, filtered, and evaporated in vacuo. The residue was purified by chromatography 
(H:EA= 1:1) to afford 71 as white solid (130 mg, 42% yield ). 300 MHz 'H NMR (CDCI3) 5 
6.47 (1H, d, J= 9.9 Hz), 6.17 (1H, d, J= 9.9 Hz), 5.91 (1H, s), 5.43 (1H, m), 5.02-5.09 (2H, 
m), 3.93-4.01 (2H, m), 3.65 (3H, s), 2.57 (1H, d, J= 10.2 Hz), 2.11-2.28 (2H, m), 1.81-1.98 
(2H, m), 1.51-1.71 (2H, m), 1.23 (3H, t, J = 7.2 Hz); 100 MHz 13C NMR (CDC13) 186.7, 
170.7, 167.4, 157.6, 151.3, 134.1, 127.7, 119.4, 108.9, 56.2, 53.2, 52.2, 42.9, 38.6, 38.0, 33.3, 
18.9,12.1. HRMS m/z for Ci7H19N05 calcd 315.1471, found 315.1478. 
Compound 72 
To a solution of compound 69 (440 mg, 1.01 mmol) in 25 mL CH^Cl^/Methanol (5/1) at 
-78 °C, ozone was bubbled till the disappearance of starting material in TLC. Argon was 
bubbled to remove excess ozone, and 170 mg of Me2S was added to the mixture. The 
reaction mixture was gradually brought up to room temperature and was stirred at that 
temperature for additional 4 h. The mixture was diluted with 20 mL of CH2CI2 and washed 
with brine. The organic layer was dried over MgSÛ4, filtered, and evaporated in vacuo. The 
residue was purified by chromatography (H:EA = 2:1) to afford 72 (400 mg, 92% yield ). 400 
MHz 'H NMR (CDCI3) 5 9.54 (1H, d, J = 4.8 Hz), 7.08 (1H, d, J = 8.4 Hz), 6.76 (1H, d, J = 
8.4 Hz), 6.73 (1H, s), 5.16 (2H, s), 3.89-3.98 (2H, m), 3.79 (3H, s), 3.58 (1H, d, /= 4.8 Hz), 
3.25 (2H, t, J= 6 Hz), 2.01-2.19 (2H, m), 1.84-1.93 (2H, m), 1.26 (3H, t, J= 7.2 Hz). 
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Compound 73 
To a solution of compound 72 (350 mg, 0.9 mmol) in 10 mL of methanol was added 
trimethylorthoformate (385 mg, 3.6 mmol) and PTSA (35 mg, 0.18 mmol). The reaction 
mixture was stirred under argon for 24 h. The solvent was concentrated and the residue was 
dissolved in 50 mL of ethyl acetate. The organic layer was washed with 10% NaHCOg and 
brine. The organic layer was dried, concentrated and purified by column chromatography 
(H:EA = 1:1) to give 73 (275 mg, 69%) as white solid. 300 MHz *H NMR (CDCI3) 6 6.97 
(1H, d,/= 8.4 Hz), 6.60 (1H, s), 6.52 (lH,d, J= 8.4 Hz), 4.14 (1H, d, J= 4.4 Hz), 4.08-4.18 
(1H, m), 3.81-3.92 (1H, m), 3.51 (3H, s), 3.23 (6H, s), 3.47 (1H, d, J= 7.4 Hz), 3.41-3.52 
(2H, m), 2.44 (1H, d,J= 4.4 Hz), 2.01-2.19 (2H, m), 1.84-1.93 (2H, m), 1.26 (3H, t,J= 7.2 
Hz). 
Compound 74 
To a suspension of NaH (29 mg, 1.2 mmol) in 5 mL of THF was added a solution of 
compound 73 (450 mg, 1.00 mmol) in 10 mL of THF at 0 °C. After stirring for 20 min, 18-
crown-6 (270 mg, 1.02 mmol) and 80 mL of THF was added and the reaction mixture was 
refluxed for 24 h under argon. The reaction mixture was cooled to room temperature and then 
quenched with 1 mL of saturated NH4CI. The organic solvent was evaporated in vacuo. The 
residue was diluted with ethyl acetate and washed with brine. The organic layer was dried 
over MgSCU, filtered, and evaporated in vacuo. The residue was purified by chromatography 
(EA:CH2C12 = 1:2) to afford 74 (265 mg, 72% yield). 400 MHz !H NMR (CDC13) 5 6.71 (1H, 
d, J= 9.9 Hz), 6.17 (1H, d, J= 9.9 Hz), 5.81 (1H, s), 4.14 (1H, d,J= 4.4 Hz), 3.98-4.19 (1H, 
m), 3.82-3.91 (1H, m) 3.73 (3H, s), 3.24 (6H, s) 2.44 (1H, d, 4.4 Hz), 2.11-2.28 (2H, m), 
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1.91-1.98 (1H, m), 1.78-1.89 (1H, m) 1.51-1.71 (2H, m), 1.23 (3H, t, .7=7.2 Hz); 100 MHz 
13C NMR (CDC13) S 170.6, 167.5, 157.4, 139.0, 134.3, 127.8, 120.2, 120.1, 109.7, 103.6, 
94.6, 56.1, 56.0, 52.1, 47.3, 38.4, 33.5, 31.6, 27.7, 12.1. 
Compound 75 
To a solution of 74 (265mg, 0.72 mmol) in ethyl acetate was carefully added 10% Pd/C 
(76 mg, 0.07 mmol) at rt. After being stirred under H2 balloon pressure at rt for 3 h, the 
mixture was filtered through celite and rinsed with ethyl acetate. The filtrate was evaporated 
in vacuo to give 75 (265 mg, 100%). 400 MHz *H NMR (CDCI3) 5 5.51 (1H, s), 4.29 (1H, d, 
J =4.4 Hz), 3.98-4.19 (2H, m), 3.63 (3H, s), 3.24 (6H, s) 2.52-2.61 (2H, m), 2.38-2.43 (1H, 
m), 2.10-2.29 (4H, m), 1.51-1.81 (4H, m), 1.23 (3H, t, J= 12 Hz); 100 MHz 13C NMR 
(CDCI3) Ô 198.1, 171.65, 167.9, 161.6, 106.3, 57.3, 55.8, 53.2, 52.5, 51.2, 37.9, 37.3, 37.0, 
36.1, 33.2, 32.4, 19.5, 11.9. 
Compound 75 
Liquid ammonia (10 mL) was collected in a three-neck flask at -78 °C containing 
compound 74 (50 mg, 0.13 mmol) and /-BuOH (48 mg, 0.65 mmol) in 2 mL of THF. Freshly 
cut lithium metal (9 mg, 1.3 mmol) was added to get a deep blue solution and mixture was 
stirred at that temperature for 30 min. Quenched with NH4C1 and the solution turned 
colorless. The mixture was warmed to room temperature and ammonia was evaporated. The 
residue was diluted with water and extracted with ethyl acetate, dried and purified by 
chromatography (EA:CH2C12 = 1:1) to yield 76 (18 mg, 45% ) as 3:1 mixture of isomers. 
Major isomer: 400 MHz 'H NMR (CDC13) 5 10.04 (1H, s), 4.69 (1H, d, J= 4.4 Hz), 
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3.60-3.70 (2H, m), 3.43 (3H,s), 3.33-3.37 (1H, m), 3.24 (3H, s) 2.41-2.82 (4H, m), 2.38-2.43 
(1H, m), 2.10-2.29 (2H, m), 1.51-1.81 (4H, m), 1.23 (3H, t, J= 7.2 Hz); 100 MHz 13C NMR 
(CDC13) ô 210.0, 201.1, 171.7, 104.3, 59.2, 56.5, 55.0, 53.4, 52.7, 43.1, 42.3, 36.7, 35.5, 35.2, 
33.0, 32.5, 19.5, 13.8. 
Minor isomer: 400 MHz !H NMR (CDCI3) ô 9.96 (1H, s), 4.49 (1H, d, J = 4.4 Hz), 
3.61-3.70 (2H, m), 3.43(3H,s), 3.33-3.37 (1H, m), 3.24 (3H, s) 2.41-2.82 (4H, m), 2.38-2.43 
(1H, m), 2.10-2.29 (2H, m), 1.5-1.8 (4H, m), 1.19 (3H, t, J= 7.2 Hz); 100 MHz. 13C NMR 
(CDCI3) ô 207.7, 200.8, 171.5,104.2, 56.7, 56.4, 53.8, 53.2, 51.2, 42.5, 40.7, 36.5, 35.3, 33.9, 
32.8, 30.6,19.2, 12.7. 
Compound 77 
To a solution of compound 74 (200 m g, 0.54 mmol) in 10 mL of MeOH was added 
LiOH (65 mg, 2.6 mmol) at room temperature. After stirring for 4 h the solvent was 
concentrated and the residue was dissolved in 5 mL water and then carefully acidified to pH 
2 with 20% aqueous HC1. The suspension was immediately extracted with ethyl acetate (5 X 
10 mL) and the combined organic extracts are dried over MgSCU and evaporated under vacuo 
to yield 77 (lllmg, 59%). 400 MHz *H NMR (CDC13) ô 5.51 (1H, s), 4.29 (1H, d, J= 4.4 
Hz), 3.98-4.19 (2H, m), 3.24 (6H, s), 2.52-2.61 (2H, m), 2.38-2.43 (1H, m), 2.10-2.29 (4H, 
m), 1.51-1.81 (4H, m), 1.23 (3H, t, 7.2 Hz). 
Compound 78 
Liquid ammonia (10 mL) was collected in a three-neck flask at -78 °C containing 
compound 77 (111 mg, 0.32 mmol) and f-BuOH (118 mg, 1.6 mmol) in 2 mL of THF. 
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Freshly cut lithium metal (22.4 mg, 3.2 mmol) was added to get a deep blue solution and 
mixture was stirred at that temperature for 30 min, quenched with NH4CI and the solution 
turned colorless. The mixture was warmed to room temperature and ammonia was 
evaporated. The residue was diluted with 5 mL of water and then carefully acidified to pH 2 
with 20% aqueous HC1. The suspension was immediately extracted with ethyl acetate (5 X 
10 mL) and the combined organic extracts are dried over MgSC>4 and evaporated under vacuo 
to yield 78 as 3:1 mixture of isomers. 
Major isomer: 400 MHz !H NMR (CDC13) 54.69 (1H, d, J =  4.4 Hz), 3.6-3.7 (2H, m), 
3.43 (3H,s), 3.33-3.37 (1H, m), 3.24 (3H, s) 2.41-2.82 (4H, m), 2.38-2.43 (1H, m), 2.10-2.29 
(2H,m), 1.51-1.80 (4H, m), 1.23 (3H, t,J= 7.2 Hz). 
Minor Isomer: 400 MHz *H NMR (CDCI3) ô 4.49 (1H, d, J= 4.4 Hz), 3.61-3.70 (2H, 
m), 3.43 (3H,s), 3.33-3.37 (1H, m), 3.24 (3H, s) 2.41-2.82 (4H, m), 2.38-2.43 (1H, m), 2.10-
2.29 (2H,m), 1.50-1.81 (4H, m), 1.19 (3H, t, J= 7.2 Hz). 
Compound 79 
To a solution of compound 78 in 10 mL of ethyl acetate was treated with freshly 
prepared CH2N2 (solution in ether) at 0 °C. After stirring at that temperature for 20 min the 
organic solvent was evaporated in vacuo. The residue was diluted with ethyl acetate and 
washed with brine. The organic layer was dried over MgSC>4, filtered, and evaporated in 
vacuo. The residue was purified by chromatography (EA:CH2Cl2 = 1:2) to afford 79 (58 mg, 
49% for two steps) as 3:1 mixture of isomers. 
Major isomer: 400 MHz *H NMR (CDCI3) 54.35 (1H, d, J= 4.4 Hz), 3.75 (3H, s), 3.60-
3.70 (2H, m), 3.43 (3H,s), 3.33-3.37 (1H, m), 3.24 (3H, s) 2.41-2.82 (4H, m), 2.38-2.43 (1H, 
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m), 2.10-2.29 (2H, m), 1.51-1.80 (4H, m), 1.23 (3H, t,J= 7.2 Hz). 
Minor Isomer : 400 MHz 'H NMR (CDC13) 64.29 (1H, d, J =  4.4 Hz), 3.75 (3H, s), 
3.60-3.70 (2H, m), 3.46 (3H, s), 3.33-3.37 (1H, m), 3.21 (3H, s) 2.41-2.82 (4H, m), 2.38-2.43 
(1H, m), 2.10-2.29 (4H ,m), 1.51-1.80 (4H, m), 1.23 (3H, t, J= 7.2 Hz). 
Compound 80 
To a solution of ester 79 (50 mg, 0.13mmol) in 2 mL of THF at 0 °C was added 0.5 mL 
of 4 N HC1. The reaction mixture was stirred at that temperature for 4 h, diluted with ethyl 
acetate (10 mL) and washed with 10% NaHCOg solution and brine. The organic layer was 
dried over MgSC>4, filtered, and evaporated in vacuo. The residue was purified by 
chromatography (EAiCHzClz = 1:2) to afford 80 (23 mg, 57%) as white powder and 
compound 81 (7 mg, 17%) 
Compound 80: 400 MHz 'H NMR (CDC13) 5 4.83 (1H, dd,J= 7.2 Hz, 4.0 Hz), 3.90- 4.00 
(1H, m), 3.80 (3H, s), 3.39 (1H, d,J= 2.8 Hz), 3.08 (1H, d,J= 7.6 Hz), 2.70-2.84 (2H, m), 
2.42 (1H, d, J= 4Hz), 2.27-2.33 (2H, m), 2.17 (1H, d,J = 2.8 Hz), 1.90-2.04 (2H, m), 1.70-
1.90 (4H, m), 1.20 (3H, t, J= 7.2 Hz); 75 MHz 13C NMR (CDC13) ô 209.6, 172.7, 166.6, 
75.2, 68.7, 62.2, 57.4, 55.6, 53.0, 41.7, 41.4, 35.9, 34.89, 33.8, 33.4, 20.1, 12.8; HRMS m/z 
for C17H22O4N calcd 321.15762, found 321.15810. 
Compound 81 
400 MHz 'H NMR (CDCI3) 59.59 (1H, d, 7=4.4 Hz), 3.75 (3H, s), 3.60-3.70 (2H, m), 
3.33-3.37 (1H, m), 2.41-2.82 (4H, m), 2.38 (1H, d, J = 4.4 Hz), 2.10-2.29 (4H, m), 1.50-1.80 
(4H, m), 1.23 (3H, t, J =1.2 Hz). 
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Compound 82 
To a solution of compound 80 (15 mg, 0.045 mmol) in 3 mL of CH2CI2 was added 
acetamidate (26 mg, 0.09 mmol) and 5 mg of CSA. The reaction mixture was stirred at room 
temperature for 24 h. The organic solvent was evaporated in vacuo. The residue was diluted 
with ethyl acetate and washed with brine. The organic layer was dried over MgSC>4, filtered, 
and evaporated in vacuo. The residue was purified by chromatography (H:EA = 1:1) to afford 
to yield 82 (15 mg, 85%). 400 MHz 'H NMR (CDCI3) ô 7.11 (2H, d,/= 8.4Hz), 6.82 (2H, d, 
J= 8.4 Hz), 4.65 (1H, dd, J = 7.2 Hz), 4.25 (2H, s), 3.90- 4.00 (1H, m), 3.80 (3H, s), 3.65 
(3H, s), 3.39 (1H, d, J= 2.8 Hz), 3.08 (1H, d, J= 7.6 Hz), 2.70-2.84 (2H, m), 2.42 (1H, d, J= 
4Hz), 2.27-2.33 (2H, m), 2.17 (lH,d, /= 2.8 Hz), 1.90-2.04 (2H, m), 1.70-1.90 (4H,m), 1.20 
(3H, t, J= 7.2 Hz). 
Compound 84 
To a solution of compound 82 (15 mg, 0.04 mmol) was added freshly prepared LDA 
(0.4 mL, 0.1 M solution) at -78°C. After stirring for 30 min TMSC1 (11 mg, 0.1 mmol) was 
added and reaction mixture was allowed to stir at that temperature for 30 min, the mixture 
was quenched with H2O. The mixture was diluted with ethyl acetate and washed with brine. 
The organic layer was dried over MgSC>4, filtered, and evaporated in vacuo to get crude 83 
and taken directly to next step. To a solution of 83 in 1 mL of CH3CN was added 5 mg of 
Pd(OAc)2 . The mixture was stirred at room temperature for 8 h. The organic solvent was 
evaporated in vacuo. The residue was diluted with ethyl acetate and washed with brine. The 
organic layer was dried over MgSÛ4, filtered, and evaporated in vacuo. The residue was 
purified by chromatography (EA:CH2Cl2 = 1:2) to afford to yield 84 (10 mg, 65 %). 400 
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MHz 'H NMR (CDCI3) 8 7.11 (2H, d, J =  8.4Hz), 6.77 (2H, d, J =  8.4 Hz), 6.75 (1H, d, J  =  
9.6 Hz), 6.10 (1H, d, J= 9.6 Hz), 4.18 (1H, d, J= 7.2 Hz), 4.32 (2H, s), 3.90- 4.00 (1H, m), 
3.80 (3H, s), 3.65 (3H, s), 3.39 (1H, d,J= 2.8 Hz), 3.08 (1H, d,J= 7.6 Hz), 2.70-2.84 (2H, 
m), 2.42 (1H, d, J= 4 Hz), 2.27-2.33 (2H, m), 2.17 (1H, d, J = 2.8 Hz), 1.71-1.90 (4H, m), 
1.22 (3H, t,/=7.2 Hz). 
Compound 85 
To a suspension of NaH (30 mg, 1.2 mmol) in 5 mL of THF was added a solution of 
compound 68 (311 mg, 1.05 mmol) in 25 mL of THF at 0 °C. After stirring for 20 min, 
HMPA (176  |xL ,  1 .02  mmol)  and  1 ,3-d ibromopropane  (600  mg,  3  mmol)  was  added .  The  
mixture was refluxed for 16 h the reaction was quenched with saturated NH4C1. The mixture 
was poured into 10 mL of water and extracted with ethyl acetate. The combined organic 
extracts was washed with brine, dried and evaporated under reduced pressure. The crude 
product was purified by chromatography (H:EA = 4:1) to give 85 (310 mg, 79%). 300 MHz 
'H NMR (CDCI3) ô 6.99 (1H, d,J= 8.4 Hz), 6.66-6.72 (2H, m), 6.28 (1H, dt,/= 12 Hz, J = 
8Hz), 5.38 (1H, d, J= 8 Hz), 5.21 (1H, d,J= 12Hz), 5.14 (2H, s) 4.02-4.18 (1H, m), 3.78-
3.89 (1H, m), 3.49 (3H, s), 3.42 (1H, d,J= 7.4 Hz), 3.35 (3H, s), 3.38-3.48 (2H, m), 2.01-
2.19 (1H, m), 1.84-1.93 (1H, m), 1.26 (3H, t,J= 7.2 Hz). 
Compound 86 
To a solution of 69 (300 mg, 0.68 mmol) in 10 mL of ethyl acetate at 0 °C was added 1 
mL of 4 N HCl. The reaction mixture was stirred at that temperature for 30 min, diluted with 
ethyl acetate (10 mL) and washed with 10% NaHC03 solution and brine. The organic layer 
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was dried over MgSCU, filtered, and evaporated in vacuo. The residue was purified by 
chromatography (H:EA = 1:1) to afford 70 (270 mg, quantitative yield). 300 MHz *H NMR 
(CDCla) Ô 6.99 (1H, d, J= 8.4 Hz), 6.66-6.72 (2H, m), 6.28 (1H, dt, J = 12 Hz, J= 8 Hz), 
5.38 (1H, d, J= 8 Hz), 5.21 (1H, d, J= 12 Hz), 4.02-4.18 (1H, m), 3.78-3.89 (1H, m), 3.49 
(3H, s), 3.42 (1H, d,J= 7.4 Hz), 3.38-3.48 (2H, m), 2.01-2.19 (1H, m), 1.84-1.93 (1H, m), 
1.26 (3H, t, 7=7.2 Hz). 
Compound 87 
To a suspension of NaH (20 mg, 0.81 mmol) in 5 mL of THF were added a solution of 
compound 70 (270 mg, 0.68mmol) in 10 mL at 0 °C. After stirring for 20 min, 18-crown-6 
(200 mg, 0.81 mmol) and 60 mL of THF was added and the reaction mixture was refluxed 
for 24 h under argon. The reaction mixture was cooled to room temperature and then 
quenched with 1 mL of saturated NH4CI. The organic solvent was evaporated in vacuo. The 
residue was diluted with ethyl acetate and washed with brine. The organic layer was dried 
over MgSCU, filtered, and evaporated in vacuo. The residue was purified by chromatography 
(H: EA= 1:1) to afford 87 as white solid (180 mg, 79% yield). 300 MHz 'H NMR (CDCI3) 5 
6.93 (1H, d, J-8.4 Hz), 6.57 (1H, s), 6.50 (1H, d, J= 8.4 Hz), 6.15 (1H, dt, J= 12 Hz, J= 8 
Hz), 5.41 (1H, d, J=8 Hz), 5.25 (1H, d,J= 12 Hz), 4.08-4.18 (1H, m), 3.81-3.92 (1H, m), 
3 .51  (3H,  s ) ,  3 .47  (1H,  d ,  J= 7 .4  Hz) ,  2 .01-2 .19  (2H,  m) ,  1 .84-1 .93  (2H,  m) ,  1 .26  (3H,  t , J  =  
7.2 Hz). 
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GENERAL CONCLUSIONS 
In this dissertation, we have investigated direct and concise strategies for natural 
products. Chapter 1 described the development of efficient annulation reaction. Phosphonium 
salts bearing an electron-withdrawing groups at gamma position as synthons for [ 3+3], [3+2] 
and [3+4] annulations. Reactions of dianions generated from phosphonium salts with bis-
electrophiles yielded five, six and seven membered rings. 
Chapter 2 described a direct approach to the synthesis of methyllycaconitine, a 
representative of the aconitine alkaloids, has been developed. A tetracyclic intermediate, 
possessing the ABEF-carbocycle skeleton has been synthesized as a result of the research 
described in this dissertation. Construction of ABE segment of methyllycaconitine and 
racemulosine through a common bicyclic intermediate was also achieved. 
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